ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 1

April 29, 2022

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST

This file is intended as a reference file for ICD-O-3 only and is not to be used for casefinding purposes. The ICD-O-3 site/type
validation program was modified to allow only for the site/histology/behavior combinations listed in this publication. All other cases
must be reviewed.
Submit any comments or questions about this document to:
Ask A SEER Registrar
https://seer.cancer.gov/registrars/contact.html

or

[email protected]
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 2
LIP C000-C006,C008-C009
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 3
LIP C000-C006,C008-C009
LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease
8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 4
LIP C000-C006,C008-C009
MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 5
BASE OF TONGUE C019
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 6
BASE OF TONGUE C019
LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease
8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
8085/3 Squamous cell carcinoma, HPV-positive
8086/3 Squamous cell carcinoma, HPV-negative

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 7
BASE OF TONGUE C019
EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma
8912/3 Spindle cell rhabdomyosarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 8
BASE OF TONGUE C019
T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome
9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 9
BASE OF TONGUE C019
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 10
TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 11
TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029
LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease
8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 12
TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029
EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma
8912/3 Spindle cell rhabdomyosarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 13
TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029
T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome
9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 14
TONGUE (EXCL BASE OF TONGUE) C020-C024,C028-C029
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 15
GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 16
GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069
LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease
8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 17
GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069
MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma
8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 18
GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069
HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]
9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 19
GUM, FLOOR OF MOUTH, & OTHER MOUTH C030-C031,C039-C041,C048-C052,C058-C062,C068-C069
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 20
SALIVARYGLAND C079-C081,C088-C089
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma

8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 21
SALIVARYGLAND C079-C081,C088-C089
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

DUCT CARCINOMA 850 8500/3 Invasive carcinoma of no special type

8502/3 Secretory carcinoma of no special type

LOBULAR AND OTHER DUCTAL CA. 852 8525/3 Polymorphous low grade adenocarcinoma

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 22
SALIVARYGLAND C079-C081,C088-C089
ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma
8561/3 Warthin tumor, malignant
8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

MYXOSARCOMA 884 8840/3 Myxosarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 23
SALIVARYGLAND C079-C081,C088-C089
RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS
8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 24
SALIVARYGLAND C079-C081,C088-C089
ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 25
SALIVARYGLAND C079-C081,C088-C089
PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS
9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 26
OROPHARNYX C090-C091,C098-C104,C108-C109
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 27
OROPHARNYX C090-C091,C098-C104,C108-C109
LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease
8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
8085/3 Squamous cell carcinoma, HPV-positive
8086/3 Squamous cell carcinoma, HPV-negative

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 28
OROPHARNYX C090-C091,C098-C104,C108-C109
MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma
8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

MAL. MELAN. IN GIANT PIGMT. NEVUS 876 8761/3 Mal. melanoma in giant pigmented nevus

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 29
OROPHARNYX C090-C091,C098-C104,C108-C109
MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS
9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 30
OROPHARNYX C090-C091,C098-C104,C108-C109
PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 31
NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 32
NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119
LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease
8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 33
NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119
MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma
8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 34
NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119
CHORDOMA 937 9370/3 Chordoma, NOS
9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 35
NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119
OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 36
NASOPHARYNX(EXCL POSTERIOR WALL) C110,C112-C113,C118-C119
CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 37
POSTERIOR WALL OF NASOPHARYNX C111
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 38
POSTERIOR WALL OF NASOPHARYNX C111
LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease
8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
8085/3 Squamous cell carcinoma, HPV-positive
8086/3 Squamous cell carcinoma, HPV-negative

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 39
POSTERIOR WALL OF NASOPHARYNX C111

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 40
POSTERIOR WALL OF NASOPHARYNX C111
CHORDOMA 937 9370/3 Chordoma, NOS
9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9719/3 NK/T-cell lymphoma, nasal and nasal-type
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 41
POSTERIOR WALL OF NASOPHARYNX C111
PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 42
HYPOPHARYNX C129-C132,C138-C139
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 43
HYPOPHARYNX C129-C132,C138-C139

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 44
HYPOPHARYNX C129-C132,C138-C139
HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]
9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 45
HYPOPHARYNX C129-C132,C138-C139
MAST CELL TUMORS 974 9740/3 Mast cell sarcoma
9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 46
PHARYNX C140,C142,C148
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 47
PHARYNX C140,C142,C148
ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 48
PHARYNX C140,C142,C148
ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 49
PHARYNX C140,C142,C148
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 50
ESOPHAGUS C150-C155,C158-C159
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell
8045/3 Combined small cell carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 51
ESOPHAGUS C150-C155,C158-C159
LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8145/3 Carcinoma, diffuse type
8147/3 Basal cell adenocarcinoma

ENDOCRINOMAS 815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8244/3 Composite carcinoid
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 52
ESOPHAGUS C150-C155,C158-C159
NEVI & MELANOMAS 872 8720/2 Melanoma in situ
8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 53
ESOPHAGUS C150-C155,C158-C159
PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS
9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 54
STOMACH C160-C166,C168-C169
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 55
STOMACH C160-C166,C168-C169
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8142/3 Linitis plastica
8143/3 Superficial spreading adenocarcinoma
8144/2 Intestinal-type adenoma, high grade
8144/3 Adenocarcinoma, intestinal type
8145/3 Carcinoma, diffuse type
8147/3 Basal cell adenocarcinoma

ENDOCRINOMAS 815 8153/3 Gastrinoma, malignant

8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm
8156/3 Somatostatinoma, malignant

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8211/3 Tubular adenocarcinoma
8213/2 Serrated dysplasia, high grade
8214/3 Parietal cell carcinoma

ADENOCA IN FAMIL POLYP COLI 822 8220/2 Adenocarcinoma in situ in familial polyp. coli
8220/3 Adenocarcinoma in adenoma. polyposis coli
8221/2 Adenocarc. in situ in mult. adenomatous polyps
8221/3 Adenocarcinoma in mult. adenomatous polyps

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 56
STOMACH C160-C166,C168-C169
CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

8512/3 Medullary carcinoma with lymphoid stroma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

STROMAL SARCOMA 893 8934/3 Carcinofibroma

8935/3 Stromal sarcoma, NOS
8936/3 Gastrointestinal stromal sarcoma

HEPATOBLASTOMA 897 8976/3 Gastroblastoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 57
STOMACH C160-C166,C168-C169
CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS
8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 58
STOMACH C160-C166,C168-C169
OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9732/3 Multiple myeloma
9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 59
STOMACH C160-C166,C168-C169
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 60
SMALL INTESTINE C170-C173,C178-C179
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8144/2 Intestinal-type adenoma, high grade
8144/3 Adenocarcinoma, intestinal type
8145/3 Carcinoma, diffuse type
8147/3 Basal cell adenocarcinoma

ENDOCRINOMAS 815 8152/3 Glucagonoma, malignant

8153/3 Gastrinoma, malignant
8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm
8156/3 Somatostatinoma, malignant
8157/3 Enteroglucagonoma, malignant

CHOLANGIOCARCINOMA 816 8163/3 Pancreatobiliary-type carcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 61
SMALL INTESTINE C170-C173,C178-C179
ADENOCA. IN ADENOMA. POLYP 821 8211/3 Tubular adenocarcinoma
8213/2 Serrated dysplasia, high grade

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

EXTRA-ADRENAL PARAGANG., MAL 869 8693/3 Extra-adrenal paraganglioma, malignant

GLOMANGIOSARCOMA 871 8710/3 Glomangiosarcoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 62
SMALL INTESTINE C170-C173,C178-C179

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

STROMAL SARCOMA 893 8934/3 Carcinofibroma

8935/3 Stromal sarcoma, NOS
8936/3 Gastrointestinal stromal sarcoma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 63
SMALL INTESTINE C170-C173,C178-C179
HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]
9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9717/3 Intestinal T-cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 64
SMALL INTESTINE C170-C173,C178-C179
MAST CELL TUMORS 974 9740/3 Mast cell sarcoma
9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9764/3 Immunoproliferative small intestinal disease

9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 65
LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 66
LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8145/3 Carcinoma, diffuse type
8147/3 Basal cell adenocarcinoma

ENDOCRINOMAS 815 8152/3 Glucagonoma, malignant

8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8211/3 Tubular adenocarcinoma
8213/3 Serrated adenocarcinoma

ADENOCA IN FAMIL POLYP COLI 822 8220/2 Adenocarcinoma in situ in familial polyp. coli
8220/3 Adenocarcinoma in adenoma. polyposis coli
8221/2 Adenocarc. in situ in mult. adenomatous polyps
8221/3 Adenocarcinoma in mult. adenomatous polyps

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma
8265/3 Micropapillary carcinoma, NOS

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 67
LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199
MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma
8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 68
LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

STROMAL SARCOMA 893 8934/3 Carcinofibroma

8935/3 Stromal sarcoma, NOS
8936/3 Gastrointestinal stromal sarcoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 69
LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199
FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9717/3 Intestinal T-cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 70
LARGE INTESTINE, (EXCL. APPENDIX) C180, C182-C189, C199
PRECURSOR LYMPHOID NEOPLASMS 981 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 71
APPENDIX C181
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 72
APPENDIX C181
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8145/3 Carcinoma, diffuse type
8147/3 Basal cell adenocarcinoma

ENDOCRINOMAS 815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8211/3 Tubular adenocarcinoma

ADENOCA IN FAMIL POLYP COLI 822 8220/2 Adenocarcinoma in situ in familial polyp. coli
8220/3 Adenocarcinoma in adenoma. polyposis coli
8221/2 Adenocarc. in situ in mult. adenomatous polyps
8221/3 Adenocarcinoma in mult. adenomatous polyps

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 73
APPENDIX C181
MUCINOUS CYSTADENOCARC., NOS 847 8470/2 Mucinous cystadenocarcinoma, non-invasive
8470/3 Mucinous cystadenocarcinoma, NOS
8471/3 Papillary mucinous cystadenocarcinoma

MUCINOUS ADENOCARCINOMA 848 8480/2 High grade appendiceal mucinous neoplasm

8480/3 Mucinous adenocarcinoma
8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 74
APPENDIX C181
LIPOSARCOMA NEOPLASMS 885 8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

STROMAL SARCOMA 893 8934/3 Carcinofibroma

8935/3 Stromal sarcoma, NOS
8936/3 Gastrointestinal stromal sarcoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 75
APPENDIX C181
FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9717/3 Intestinal T-cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 76
APPENDIX C181
PRECURSOR LYMPHOID NEOPLASMS 981 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 77
RECTUM C209
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 78
RECTUM C209
TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8145/3 Carcinoma, diffuse type
8147/3 Basal cell adenocarcinoma

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8211/3 Tubular adenocarcinoma
8213/3 Serrated adenocarcinoma

ADENOCA IN FAMIL POLYP COLI 822 8220/2 Adenocarcinoma in situ in familial polyp. coli
8220/3 Adenocarcinoma in adenoma. polyposis coli
8221/2 Adenocarc. in situ in mult. adenomatous polyps
8221/3 Adenocarcinoma in mult. adenomatous polyps

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma
8265/3 Micropapillary carcinoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 79
RECTUM C209
MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

MAL. MELAN. IN GIANT PIGMT. NEVUS 876 8761/3 Mal. melanoma in giant pigmented nevus

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 80
RECTUM C209
SARCOMA, NOS 880 8800/3 Sarcoma, NOS
8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

STROMAL SARCOMA 893 8934/3 Carcinofibroma

8935/3 Stromal sarcoma, NOS
8936/3 Gastrointestinal stromal sarcoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 81
RECTUM C209
HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS
9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9717/3 Intestinal T-cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 82
RECTUM C209
PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS
9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 83
ANAL CANAL & ANUS C210-C212,C218
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8077/2 Squamous intraepithelial neoplasia, grade III
8078/3 Squamous cell carcinoma with horn formation

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 84
ANAL CANAL & ANUS C210-C212,C218
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8145/3 Carcinoma, diffuse type
8147/3 Basal cell adenocarcinoma

ENDOCRINOMAS 815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8215/3 Adenocarcinoma of anal glands

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

DUCT CARCINOMA 850 8500/2 Intraductal carcinoma, noninfiltrating, NOS

8500/3 Invasive carcinoma of no special type
8503/2 Noninfiltrating intraductal papillary adenocarcinoma
8503/3 Intraductal papillary adenocarcinoma with invasion
8504/2 Noninfiltrating intracystic carcinoma
8504/3 Intracystic carcinoma, NOS

PAGET DISEASE, EXTRAMAMMARY 854 8542/3 Paget disease, extramammary

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 85
ANAL CANAL & ANUS C210-C212,C218
ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma
8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 86
ANAL CANAL & ANUS C210-C212,C218
HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS
9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9717/3 Intestinal T-cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 87
ANAL CANAL & ANUS C210-C212,C218
PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS
9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 88
LIVER C220
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ENDOCRINOMAS 815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm

CHOLANGIOCARCINOMA 816 8160/3 Cholangiocarcinoma

8161/3 Bile duct cystadenocarcinoma

HEPATOCELLULAR CARCINOMA, NOS 817 8170/3 Hepatocellular carcinoma, NOS

8171/3 Hepatocellular carcinoma, fibrolamellar
8172/3 Hepatocellular carcinoma, scirrhous
8173/3 Hepatocellular carcinoma, spindle cell variant
8174/3 Hepatocellular carcinoma, clear cell type
8175/3 Hepatocellular carcinoma, pleomorphic type

COMB HEPATOCEL CA. & CHOLANG 818 8180/3 Comb. hepatocel. carcinoma & cholangiocarcinoma

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 89
LIVER C220

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCINOUS CYSTADENOCARC., NOS 847 8470/2 Mucinous cystadenocarcinoma, non-invasive

8470/3 Mucinous cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

DUCT CARCINOMA 850 8500/2 Intraductal carcinoma, noninfiltrating, NOS

8500/3 Invasive carcinoma of no special type
8501/2 Comedocarcinoma, non-infiltrating
8501/3 Comedocarcinoma, NOS
8503/2 Noninfiltrating intraductal papillary adenocarcinoma
8503/3 Intraductal papillary adenocarcinoma with invasion
8504/2 Noninfiltrating intracystic carcinoma
8504/3 Intracystic carcinoma, NOS
8507/2 Intraductal micropapillary carcinoma
8508/3 Cystic hypersecretory carcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

HEPATOBLASTOMA 897 8970/3 Hepatoblastoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8991/3 Embryonal sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 90
LIVER C220

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

9124/3 Kupffer cell sarcoma

HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant

9133/3 Epithelioid hemangioendothelioma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 91
LIVER C220
OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 92
LIVER C220
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 93
INTRAHEPATICBILE DUCTS C221
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

CHOLANGIOCARCINOMA 816 8160/3 Cholangiocarcinoma

8161/3 Bile duct cystadenocarcinoma
8162/3 Klatskin tumor

HEPATOCELLULAR CARCINOMA, NOS 817 8170/3 Hepatocellular carcinoma, NOS

8171/3 Hepatocellular carcinoma, fibrolamellar
8172/3 Hepatocellular carcinoma, scirrhous
8173/3 Hepatocellular carcinoma, spindle cell variant
8174/3 Hepatocellular carcinoma, clear cell type
8175/3 Hepatocellular carcinoma, pleomorphic type

COMB HEPATOCEL CA. & CHOLANG 818 8180/3 Comb. hepatocel. carcinoma & cholangiocarcinoma

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 94
INTRAHEPATICBILE DUCTS C221
BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

DUCT CARCINOMA 850 8500/2 Intraductal carcinoma, noninfiltrating, NOS

8500/3 Invasive carcinoma of no special type
8501/2 Comedocarcinoma, non-infiltrating
8501/3 Comedocarcinoma, NOS
8503/2 Noninfiltrating intraductal papillary adenocarcinoma
8503/3 Intraductal papillary adenocarcinoma with invasion
8504/2 Noninfiltrating intracystic carcinoma
8504/3 Intracystic carcinoma, NOS
8507/2 Intraductal micropapillary carcinoma
8508/3 Cystic hypersecretory carcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant

9133/3 Epithelioid hemangioendothelioma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 95
INTRAHEPATICBILE DUCTS C221
HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS
9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 96
INTRAHEPATICBILE DUCTS C221
PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS
9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 97
GALLBLADDER& EXTRAHEPATICBILE DUCTS C239-C241,C248-C249
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8144/2 Intestinal-type adenoma, high grade
8144/3 Adenocarcinoma, intestinal type
8147/3 Basal cell adenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 98
GALLBLADDER& EXTRAHEPATICBILE DUCTS C239-C241,C248-C249
ENDOCRINOMAS 815 8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm

CHOLANGIOCARCINOMA 816 8160/3 Cholangiocarcinoma

8161/3 Bile duct cystadenocarcinoma
8162/3 Klatskin tumor
8163/3 Pancreatobiliary-type carcinoma

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCINOUS CYSTADENOCARC., NOS 847 8470/3 Mucinous cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

DUCT CARCINOMA 850 8500/2 Intraductal carcinoma, noninfiltrating, NOS

8500/3 Invasive carcinoma of no special type
8501/2 Comedocarcinoma, non-infiltrating
8501/3 Comedocarcinoma, NOS
8503/2 Noninfiltrating intraductal papillary adenocarcinoma
8503/3 Intraductal papillary adenocarcinoma with invasion
8504/2 Noninfiltrating intracystic carcinoma
8504/3 Intracystic carcinoma, NOS
8507/2 Intraductal micropapillary carcinoma
8508/3 Cystic hypersecretory carcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 99
GALLBLADDER& EXTRAHEPATICBILE DUCTS C239-C241,C248-C249
ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia
8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 100
GALLBLADDER& EXTRAHEPATICBILE DUCTS C239-C241,C248-C249
HODGKIN LYMPHOMA, NOD. SCLER. 966 9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 101
GALLBLADDER& EXTRAHEPATICBILE DUCTS C239-C241,C248-C249
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 102
PANCREAS C250-C254,C257-C259
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 103
PANCREAS C250-C254,C257-C259
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma
8148/2 Glandular intraepithelial neoplasia, grade III

ENDOCRINOMAS 815 8150/3 Islet cell carcinoma

8151/3 Insulinoma, malignant
8152/3 Glucagonoma, malignant
8153/3 Gastrinoma, malignant
8154/3 Mixed neuroendocrine non-neuroendocrine neoplasm
8155/3 Vipoma
8156/3 Somatostatinoma, malignant
8157/3 Enteroglucagonoma, malignant
8158/3 ACTH-producing tumor

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8211/3 Tubular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8323/3 Mixed cell adenocarcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 104
PANCREAS C250-C254,C257-C259
MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

8441/3 Serous cystadenocarcinoma

PAPILLARY CYSTADENOCA., NOS 845 8450/3 Papillary cystadenocarcinoma, NOS

8452/3 Solid pseudopapillary carcinoma
8453/2 Intraductal papillary-mucinous carcinoma, non-inv.
8453/3 Intraductal papillary-mucinous carcinoma, invasive
8455/2 Intraductal oncocytic papillary neoplasm, NOS
8455/3 Intraductal oncocytic papillary neoplasms with associated invasive
carcinoma

MUCINOUS CYSTADENOCARC., NOS 847 8470/2 Mucinous cystadenocarcinoma, non-invasive

8470/3 Mucinous cystadenocarcinoma, NOS
8471/3 Papillary mucinous cystadenocarcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

DUCT CARCINOMA 850 8500/2 Intraductal carcinoma, noninfiltrating, NOS

8500/3 Invasive carcinoma of no special type
8501/2 Comedocarcinoma, non-infiltrating
8501/3 Comedocarcinoma, NOS
8503/2 Noninfiltrating intraductal papillary adenocarcinoma
8503/3 Intraductal papillary adenocarcinoma with invasion
8504/2 Noninfiltrating intracystic carcinoma
8504/3 Intracystic carcinoma, NOS
8507/2 Intraductal micropapillary carcinoma
8508/3 Cystic hypersecretory carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

8514/3 Duct carcinoma, desmoplastic type

LOBULAR AND OTHER DUCTAL CA. 852 8521/3 Infiltrating ductular carcinoma

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma
8552/3 Mixed acinar ductal carcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 105
PANCREAS C250-C254,C257-C259
ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia
8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

PANCREATOBLASTOMA 897 8971/3 Pancreatoblastoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 106
PANCREAS C250-C254,C257-C259
ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 107
PANCREAS C250-C254,C257-C259
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 108
UNSPECIFIED DIGEST. ORGANS C260,C268-C269
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 109
UNSPECIFIED DIGEST. ORGANS C260,C268-C269
LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ENDOCRINOMAS 815 8152/3 Glucagonoma, malignant

8153/3 Gastrinoma, malignant
8156/3 Somatostatinoma, malignant
8157/3 Enteroglucagonoma, malignant

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8211/3 Tubular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 110
UNSPECIFIED DIGEST. ORGANS C260,C268-C269
CARCINOID TUMOR, MALIGNANT 824 8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8251/3 Alveolar adenocarcinoma

8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

ENDOMETRIOID ADENOCARCINOMA 838 8380/3 Endometrioid carcinoma

SWEAT GLAND ADENOCARCINOMA 840 8401/3 Apocrine adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

DUCT CARCINOMA 850 8503/2 Noninfiltrating intraductal papillary adenocarcinoma

8503/3 Intraductal papillary adenocarcinoma with invasion
8504/2 Noninfiltrating intracystic carcinoma
8504/3 Intracystic carcinoma, NOS

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

LOBULAR AND OTHER DUCTAL CA. 852 8521/3 Infiltrating ductular carcinoma

PAGET DISEASE, EXTRAMAMMARY 854 8542/3 Paget disease, extramammary

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 111
UNSPECIFIED DIGEST. ORGANS C260,C268-C269
ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma
8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

EXTRA-ADRENAL PARAGANG., MAL 869 8693/3 Extra-adrenal paraganglioma, malignant

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 112
UNSPECIFIED DIGEST. ORGANS C260,C268-C269
MYXOSARCOMA 884 8840/3 Myxosarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

STROMAL SARCOMA 893 8935/3 Stromal sarcoma, NOS

8936/3 Gastrointestinal stromal sarcoma

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 113
UNSPECIFIED DIGEST. ORGANS C260,C268-C269
SYNOVIAL SARCOMA, NOS 904 9040/3 Synovial sarcoma, NOS
9041/3 Synovial sarcoma, spindle cell
9042/3 Synovial sarcoma, epithelioid cell
9043/3 Synovial sarcoma, biphasic
9044/3 Clear cell sarcoma,NOS (except of kidney M-8964/3)

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

CHORIOCARCINOMA 910 9100/3 Choriocarcinoma

9101/3 Choriocarcinoma combined w/ other germ cell elements
9105/3 Trophoblastic tumor, epithelioid

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant

9133/3 Epithelioid hemangioendothelioma, malignant

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

LYMPHANGIOSARCOMA 917 9170/3 Lymphangiosarcoma

GT. CELL TUMOR OF BONE, MAL. 925 9251/3 Malignant giant cell tumor of soft parts
9252/3 Malignant tenosynovial giant cell tumor

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 114
UNSPECIFIED DIGEST. ORGANS C260,C268-C269
NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS
9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant

9561/3 MPNST with rhabdomyoblastic differentiation

PERINEURIOMA 957 9571/3 Perineurioma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 115
UNSPECIFIED DIGEST. ORGANS C260,C268-C269
FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9717/3 Intestinal T-cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 116
UNSPECIFIED DIGEST. ORGANS C260,C268-C269
PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS
9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 117
NASAL CAVITY (INCLUDING NASAL CARTILAGE) C300
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma
8023/3 NUT carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 118
NASAL CAVITY (INCLUDING NASAL CARTILAGE) C300
LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 119
NASAL CAVITY (INCLUDING NASAL CARTILAGE) C300
ADENOCA. WITH METAPLASIA 857 8575/3 Metaplastic carcinoma, NOS

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 120
NASAL CAVITY (INCLUDING NASAL CARTILAGE) C300
EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma
8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

SYNOVIAL SARCOMA, NOS 904 9045/3 Biphenotypic sinonasal sarcoma

CHONDROSARCOMA, NOS 922 9220/3 Chondrosarcoma, NOS

9221/3 Juxtacortical chondrosarcoma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

OLFACTORY NEUROGENIC TUMOR 952 9520/3 Olfactory neurogenic tumor

9521/3 Olfactory neurcytoma
9522/3 Olfactory neuroblastoma
9523/3 Olfactory neuroepithelioma

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant

9561/3 MPNST with rhabdomyoblastic differentiation

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 121
NASAL CAVITY (INCLUDING NASAL CARTILAGE) C300
HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]
9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 122
NASAL CAVITY (INCLUDING NASAL CARTILAGE) C300
MAST CELL TUMORS 974 9740/3 Mast cell sarcoma
9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 123
MIDDLE EAR C301
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 124
MIDDLE EAR C301
LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 125
MIDDLE EAR C301
ADENOCA. WITH METAPLASIA 857 8575/3 Metaplastic carcinoma, NOS

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 126
MIDDLE EAR C301
EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma
8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

OLFACTORY NEUROGENIC TUMOR 952 9520/3 Olfactory neurogenic tumor

9521/3 Olfactory neurcytoma
9522/3 Olfactory neuroblastoma
9523/3 Olfactory neuroepithelioma

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant

9561/3 MPNST with rhabdomyoblastic differentiation

PERINEURIOMA 957 9571/3 Perineurioma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 127
MIDDLE EAR C301
HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]
9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 128
MIDDLE EAR C301
MAST CELL TUMORS 974 9740/3 Mast cell sarcoma
9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 129
SINUSES C310-C313, C318
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 130
SINUSES C310-C313, C318
LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
8085/3 Squamous cell carcinoma, HPV-positive
8086/3 Squamous cell carcinoma, HPV-negative

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 131
SINUSES C310-C313, C318
ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia
8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 132
SINUSES C310-C313, C318
RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS
8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

SYNOVIAL SARCOMA, NOS 904 9045/3 Biphenotypic sinonasal sarcoma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

OLFACTORY NEUROGENIC TUMOR 952 9520/3 Olfactory neurogenic tumor

9521/3 Olfactory neurcytoma
9522/3 Olfactory neuroblastoma
9523/3 Olfactory neuroepithelioma

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant

9561/3 MPNST with rhabdomyoblastic differentiation

PERINEURIOMA 957 9571/3 Perineurioma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 133
SINUSES C310-C313, C318
HODGKIN LYMPHOMA 965 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 134
SINUSES C310-C313, C318
MAST CELL TUMORS 974 9740/3 Mast cell sarcoma
9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 135
ACCESSORYSINUS, NOS C319
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma
8023/3 NUT carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 136
ACCESSORYSINUS, NOS C319
LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
8085/3 Squamous cell carcinoma, HPV-positive
8086/3 Squamous cell carcinoma, HPV-negative

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 137
ACCESSORYSINUS, NOS C319
ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia
8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 138
ACCESSORYSINUS, NOS C319
RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS
8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

SYNOVIAL SARCOMA, NOS 904 9045/3 Biphenotypic sinonasal sarcoma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

OLFACTORY NEUROGENIC TUMOR 952 9520/3 Olfactory neurogenic tumor

9521/3 Olfactory neurcytoma
9522/3 Olfactory neuroblastoma
9523/3 Olfactory neuroepithelioma

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant

9561/3 MPNST with rhabdomyoblastic differentiation

PERINEURIOMA 957 9571/3 Perineurioma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 139
ACCESSORYSINUS, NOS C319
HODGKIN LYMPHOMA 965 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 140
ACCESSORYSINUS, NOS C319
MAST CELL TUMORS 974 9740/3 Mast cell sarcoma
9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 141
LARYNX C320-C323,C328-C329
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 142
LARYNX C320-C323,C328-C329
LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 143
LARYNX C320-C323,C328-C329
FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS
8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

CHONDROSARCOMA, NOS 922 9220/3 Chondrosarcoma, NOS

9221/3 Juxtacortical chondrosarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 144
LARYNX C320-C323,C328-C329
FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 145
LARYNX C320-C323,C328-C329
PRECURSOR LYMPHOID NEOPLASMS 981 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 146
TRACHEA C339
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

NON-SMALL CELL CARCINOMA, NOS 804 8046/3 Non-small cell carcinoma

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8042/3 Oat cell carcinoma
8043/3 Small cell carcinoma, fusiform cell
8044/3 Small cell carcinoma, intermediate cell
8045/3 Combined small cell carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 147
TRACHEA C339
SQUAMOUS CELL CARCINOMA, NOS 807 8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8250/3 Lepidic adenocarcinoma

8252/3 Bronchiolo-alveolar carcinoma, non-mucinous
8253/3 Invasive mucinous adenocarcinoma
8254/3 Mixed invasive mucinous and non-mucinous adenocarcinoma
8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 148
TRACHEA C339
HEPATOBLASTOMA 897 8972/3 Pulmonary blastoma
8973/3 Pleuropulmonary blastoma

CHONDROSARCOMA, NOS 922 9220/3 Chondrosarcoma, NOS

9221/3 Juxtacortical chondrosarcoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 149
LUNG & BRONCHUS C340-C343,C348-C349
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma
8023/3 NUT carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

NON-SMALL CELL CARCINOMA, NOS 804 8046/3 Non-small cell carcinoma

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8042/3 Oat cell carcinoma
8043/3 Small cell carcinoma, fusiform cell
8044/3 Small cell carcinoma, intermediate cell
8045/3 Combined small cell carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 150
LUNG & BRONCHUS C340-C343,C348-C349
SQUAMOUS CELL CARCINOMA, NOS 807 8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8083/3 Basaloid squamous cell carcinoma

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8250/2 Adenocarcinoma in situ, non-mucinous

8250/3 Lepidic adenocarcinoma
8251/3 Alveolar adenocarcinoma
8252/3 Bronchiolo-alveolar carcinoma, non-mucinous
8253/2 Adenocarcinoma in situ, mucinous
8253/3 Invasive mucinous adenocarcinoma
8254/3 Mixed invasive mucinous and non-mucinous adenocarcinoma
8255/3 Adenocarcinoma with mixed subtypes
8256/3 Minimally invasive adenocarcinoma, non-mucinous
8257/3 Minimally invasive adenocarcinoma, mucinous
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 151
LUNG & BRONCHUS C340-C343,C348-C349

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8265/3 Micropapillary carcinoma, NOS

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

FOLLICULAR ADENOCARCINOMA, NOS 833 8333/3 Fetal adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

GLOMANGIOSARCOMA 871 8714/3 PEComa, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 152
LUNG & BRONCHUS C340-C343,C348-C349
FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS
8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYXOSARCOMA 884 8842/3 Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

HEPATOBLASTOMA 897 8972/3 Pulmonary blastoma

8973/3 Pleuropulmonary blastoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

MESOTHELIOMA 905 9050/2 Mesothelioma, in situ

9050/3 Mesothelioma, malignant
9051/3 Fibrous mesothelioma, malignant
9052/3 Epithel. mesothelioma, mal.
9053/3 Mesothelioma, biphasic, malignant

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 153
LUNG & BRONCHUS C340-C343,C348-C349
HEMANGIOENDOTHELIOMA 913 9133/3 Epithelioid hemangioendothelioma, malignant
9137/3 Intimal sarcoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

LYMPHANGIOSARCOMA 917 9174/3 Lymphangioleiomyomatosis

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
9678/3 Primary effusion lymphoma
9679/3 Mediastinal large B-cell lymphoma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 154
LUNG & BRONCHUS C340-C343,C348-C349
T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome
9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 155
LUNG & BRONCHUS C340-C343,C348-C349
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 156
THYMUS C379
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma
8023/3 NUT carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/3 Squamous cell carcinoma, NOS

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

THYMOMA, MALIGNANT 858 8580/3 Thymoma, malignant, NOS

8581/3 Thymoma, type A, malignant
8582/3 Thymoma, type AB, malignant
8583/3 Thymoma, type B1, malignant
8584/3 Thymoma, type B2, malignant
8585/3 Thymoma, type B3, malignant
8586/3 Thymic carcinoma, NOS
8588/3 Spindle epithelial tumor with thymus-like element
8589/3 Carcinoma showing thymus-like element

TERATOMA 908 9086/3 Germ cell tumors with associated hematological malignancy
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 157
THYMUS C379
MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS
9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
9679/3 Mediastinal large B-cell lymphoma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 158
THYMUS C379
PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 159
HEART C380
BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

HEMANGIOENDOTHELIOMA 913 9137/3 Intimal sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
9678/3 Primary effusion lymphoma
9679/3 Mediastinal large B-cell lymphoma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
9689/3 Splenic marginal zone B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9700/3 Mycosis fungoides

9701/3 Sezary syndrome
9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
9708/3 Subcutaneous panniculitis-like T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 160
HEART C380
T-CELL LYMPHOMAS 970 9709/3 Cutaneous T-cell lymphoma, NOS

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9717/3 Intestinal T-cell lymphoma
9718/3 Primary cutan. CD30+ T-cell lymphoprolif. disorder
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9735/3 Plasmablastic lymphoma

9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9751/3 Langerhans cell histiocytosis, NOS
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 161
MEDIASTINUM C381-C383, C388
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

PARAGANGLIOMA 868 8680/3 Paraganglioma, malignant

EXTRA-ADRENAL PARAGANG., MAL 869 8693/3 Extra-adrenal paraganglioma, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma
8859/3 Myxoid pleomorphic liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 162
MEDIASTINUM C381-C383, C388
RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS
8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9061/3 Seminoma, NOS
9062/3 Seminoma, anaplastic
9063/3 Spermatocytic seminoma
9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

CHORIOCARCINOMA 910 9100/3 Choriocarcinoma

9101/3 Choriocarcinoma combined w/ other germ cell elements
9105/3 Trophoblastic tumor, epithelioid

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 163
MEDIASTINUM C381-C383, C388
NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant
9561/3 MPNST with rhabdomyoblastic differentiation

PERINEURIOMA 957 9571/3 Perineurioma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
9678/3 Primary effusion lymphoma
9679/3 Mediastinal large B-cell lymphoma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 164
MEDIASTINUM C381-C383, C388
OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 165
MEDIASTINUM C381-C383, C388
CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 166
PLEURA C384
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

HEPATOBLASTOMA 897 8973/3 Pleuropulmonary blastoma

MESOTHELIOMA 905 9050/2 Mesothelioma, in situ

9050/3 Mesothelioma, malignant
9051/3 Fibrous mesothelioma, malignant
9052/3 Epithel. mesothelioma, mal.
9053/3 Mesothelioma, biphasic, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 167
PLEURA C384
HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]
9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
9678/3 Primary effusion lymphoma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 168
PLEURA C384
MAST CELL TUMORS 974 9740/3 Mast cell sarcoma
9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 169
RESPIRATORY, NOS C390,C398-C399
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 170
RESPIRATORY, NOS C390,C398-C399
TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8250/3 Lepidic adenocarcinoma

8251/3 Alveolar adenocarcinoma
8252/3 Bronchiolo-alveolar carcinoma, non-mucinous
8253/3 Invasive mucinous adenocarcinoma
8254/3 Mixed invasive mucinous and non-mucinous adenocarcinoma
8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 171
RESPIRATORY, NOS C390,C398-C399
GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma
8323/3 Mixed cell adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 172
RESPIRATORY, NOS C390,C398-C399
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

PERIPHERAL NEUROECTODERMAL TUMOR 936 9364/3 Peripheral neuroectodermal tumor

9365/3 Askin tumor

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 173
BONES & JOINTS (EXCL SKULL AND FACE, MANDIBLE) C400-C403,C408-C409,C412-C414,C418-C419
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8812/3 Periosteal fibrosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYXOSARCOMA 884 8840/3 Myxosarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

SYNOVIAL SARCOMA, NOS 904 9040/3 Synovial sarcoma, NOS

9041/3 Synovial sarcoma, spindle cell
9042/3 Synovial sarcoma, epithelioid cell
9043/3 Synovial sarcoma, biphasic

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 174
BONES & JOINTS (EXCL SKULL AND FACE, MANDIBLE) C400-C403,C408-C409,C412-C414,C418-C419
HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant
9133/3 Epithelioid hemangioendothelioma, malignant

OSTEOSARCOMA, NOS 918 9180/3 Osteosarcoma, NOS

9181/3 Chondroblastic osteosarcoma
9182/3 Fibroblastic osteosarcoma
9183/3 Telangiectatic osteosarcoma
9184/3 Osteosarcoma in Paget disease
9185/3 Small cell osteosarcoma
9186/3 Central osteosarcoma
9187/3 Instrosseous well differentiated osteosarcoma

JUXTACORTICAL OSTEOSARCOMA 919 9192/3 Parosteal osteosarcoma

9193/3 Periosteal osteosarcoma
9194/3 High grade surface osteosarcoma
9195/3 Intracortical osteosarcoma

CHONDROSARCOMA, NOS 922 9220/3 Chondrosarcoma, NOS

9221/3 Juxtacortical chondrosarcoma

CHONDROBLASTOMA, MALIGNANT 923 9230/3 Chondroblastoma, malignant

9231/3 Myxoid chondrosarcoma

OSSEOUS & CHONDROMATOUS NEOPLASMS 924 9240/3 Mesenchymal chondrosarcoma

9242/3 Clear cell chondrosarcoma
9243/3 Dedifferentiated chondrosarcoma

GT. CELL TUMOR OF BONE, MAL. 925 9250/3 Giant cell tumor of bone, malignant
9251/3 Malignant giant cell tumor of soft parts

EWING SARCOMA 926 9260/3 Ewing sarcoma

9261/3 Adamantinoma of long bones

ODONTOGENIC TUMOR, MAL. 927 9270/3 Odontogenic tumor, malignant

AMELOBLASTIC ODONTOSARCOMA 929 9290/3 Ameloblastic odontosarcoma

AMELOBLASTOMA, MALIGNANT 931 9310/3 Ameloblastoma, malignant

AMELOBLASTIC FIBROSARCOMA 933 9330/3 Ameloblastic fibrosarcoma

ODONTOGENIC CARCINOSARCOMA 934 9342/3 Odontogenic carcinosarcoma

PERIPHERAL NEUROECTODERMAL TUMOR 936 9364/3 Peripheral neuroectodermal tumor

9365/3 Askin tumor
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 175
BONES & JOINTS (EXCL SKULL AND FACE, MANDIBLE) C400-C403,C408-C409,C412-C414,C418-C419
CHORDOMA 937 9370/3 Chordoma, NOS
9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 176
BONES & JOINTS (EXCL SKULL AND FACE, MANDIBLE) C400-C403,C408-C409,C412-C414,C418-C419
OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9732/3 Multiple myeloma
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 177
BONES & JOINTS (EXCL SKULL AND FACE, MANDIBLE) C400-C403,C408-C409,C412-C414,C418-C419
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 178
BONES OF SKULL AND FACE C410
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8812/3 Periosteal fibrosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYXOSARCOMA 884 8840/3 Myxosarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

SYNOVIAL SARCOMA, NOS 904 9040/3 Synovial sarcoma, NOS

9041/3 Synovial sarcoma, spindle cell
9042/3 Synovial sarcoma, epithelioid cell
9043/3 Synovial sarcoma, biphasic

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 179
BONES OF SKULL AND FACE C410
HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant
9133/3 Epithelioid hemangioendothelioma, malignant

OSTEOSARCOMA, NOS 918 9180/3 Osteosarcoma, NOS

9181/3 Chondroblastic osteosarcoma
9182/3 Fibroblastic osteosarcoma
9183/3 Telangiectatic osteosarcoma
9184/3 Osteosarcoma in Paget disease
9185/3 Small cell osteosarcoma
9186/3 Central osteosarcoma
9187/3 Instrosseous well differentiated osteosarcoma

JUXTACORTICAL OSTEOSARCOMA 919 9192/3 Parosteal osteosarcoma

9193/3 Periosteal osteosarcoma
9194/3 High grade surface osteosarcoma
9195/3 Intracortical osteosarcoma

CHONDROSARCOMA, NOS 922 9220/3 Chondrosarcoma, NOS

9221/3 Juxtacortical chondrosarcoma

CHONDROBLASTOMA, MALIGNANT 923 9230/3 Chondroblastoma, malignant

9231/3 Myxoid chondrosarcoma

OSSEOUS & CHONDROMATOUS NEOPLASMS 924 9240/3 Mesenchymal chondrosarcoma

9242/3 Clear cell chondrosarcoma
9243/3 Dedifferentiated chondrosarcoma

GT. CELL TUMOR OF BONE, MAL. 925 9250/3 Giant cell tumor of bone, malignant
9251/3 Malignant giant cell tumor of soft parts

EWING SARCOMA 926 9260/3 Ewing sarcoma

9261/3 Adamantinoma of long bones

ODONTOGENIC TUMOR, MAL. 927 9270/3 Odontogenic tumor, malignant

AMELOBLASTIC ODONTOSARCOMA 929 9290/3 Ameloblastic odontosarcoma

ODONTOGENIC TUMOR, MAL. 930 9302/3 Ghost cell odontogenic carcinoma

AMELOBLASTOMA, MALIGNANT 931 9310/3 Ameloblastoma, malignant

AMELOBLASTIC FIBROSARCOMA 933 9330/3 Ameloblastic fibrosarcoma

ODONTOGENIC CARCINOSARCOMA 934 9341/3 Clear cell odontogenic carcinoma

9342/3 Odontogenic carcinosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 180
BONES OF SKULL AND FACE C410
PERIPHERAL NEUROECTODERMAL TUMOR 936 9364/3 Peripheral neuroectodermal tumor
9365/3 Askin tumor

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 181
BONES OF SKULL AND FACE C410
OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9732/3 Multiple myeloma
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 182
BONES OF SKULL AND FACE C410
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 183
MANDIBLE C411
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8812/3 Periosteal fibrosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYXOSARCOMA 884 8840/3 Myxosarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

SYNOVIAL SARCOMA, NOS 904 9040/3 Synovial sarcoma, NOS

9041/3 Synovial sarcoma, spindle cell
9042/3 Synovial sarcoma, epithelioid cell
9043/3 Synovial sarcoma, biphasic

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 184
MANDIBLE C411
HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant
9133/3 Epithelioid hemangioendothelioma, malignant

OSTEOSARCOMA, NOS 918 9180/3 Osteosarcoma, NOS

9181/3 Chondroblastic osteosarcoma
9182/3 Fibroblastic osteosarcoma
9183/3 Telangiectatic osteosarcoma
9184/3 Osteosarcoma in Paget disease
9185/3 Small cell osteosarcoma
9186/3 Central osteosarcoma
9187/3 Instrosseous well differentiated osteosarcoma

JUXTACORTICAL OSTEOSARCOMA 919 9192/3 Parosteal osteosarcoma

9193/3 Periosteal osteosarcoma
9194/3 High grade surface osteosarcoma
9195/3 Intracortical osteosarcoma

CHONDROSARCOMA, NOS 922 9220/3 Chondrosarcoma, NOS

9221/3 Juxtacortical chondrosarcoma

CHONDROBLASTOMA, MALIGNANT 923 9230/3 Chondroblastoma, malignant

9231/3 Myxoid chondrosarcoma

OSSEOUS & CHONDROMATOUS NEOPLASMS 924 9240/3 Mesenchymal chondrosarcoma

9242/3 Clear cell chondrosarcoma
9243/3 Dedifferentiated chondrosarcoma

GT. CELL TUMOR OF BONE, MAL. 925 9250/3 Giant cell tumor of bone, malignant
9251/3 Malignant giant cell tumor of soft parts

EWING SARCOMA 926 9260/3 Ewing sarcoma

9261/3 Adamantinoma of long bones

ODONTOGENIC TUMOR, MAL. 927 9270/3 Odontogenic tumor, malignant

AMELOBLASTIC ODONTOSARCOMA 929 9290/3 Ameloblastic odontosarcoma

ODONTOGENIC TUMOR, MAL. 930 9302/3 Ghost cell odontogenic carcinoma

AMELOBLASTOMA, MALIGNANT 931 9310/3 Ameloblastoma, malignant

AMELOBLASTIC FIBROSARCOMA 933 9330/3 Ameloblastic fibrosarcoma

ODONTOGENIC CARCINOSARCOMA 934 9341/3 Clear cell odontogenic carcinoma

9342/3 Odontogenic carcinosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 185
MANDIBLE C411
PERIPHERAL NEUROECTODERMAL TUMOR 936 9364/3 Peripheral neuroectodermal tumor
9365/3 Askin tumor

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 186
MANDIBLE C411
OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9732/3 Multiple myeloma
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 187
MANDIBLE C411
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 188
BLOOD, BONE MARROW, & HEMATOPOIETICSYS C420, C421, C424
PERIPHERAL NEUROECTODERMAL TUMOR 936 9366/3 Round cell sarcoma with EWSR1-non-ETS fusions
9367/3 CIC-rearranged sarcoma
9368/3 Sarcoma with BCOR genetic alterations

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
9678/3 Primary effusion lymphoma
9679/3 Mediastinal large B-cell lymphoma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
9689/3 Splenic marginal zone B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 189
BLOOD, BONE MARROW, & HEMATOPOIETICSYS C420, C421, C424
OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9732/3 Multiple myeloma
9733/3 Plasma cell leukemia
9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9742/3 Mast cell leukemia

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9760/3 Immunoproliferative disease, NOS

9761/3 Waldenstrom macroglobulinemia
9762/3 Heavy chain disease, NOS

LEUKEMIA, NOS 980 9800/3 Leukemia, NOS

9801/3 Acute leukemia, NOS
9805/3 Acute biphenotypic leukemia
9806/3 Mixed phenotype acute leukemia with t(9;22)(q34;q11.2);BCR-ABL1
9807/3 Mixed phenotype acute leukemia with t(v;11q23);MLL rearranged
9808/3 Mixed phenotype acute leukemia, B/myeloid, NOS
9809/3 Mixed phenotype acute leukemia, T/myeloid, NOS

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 190
BLOOD, BONE MARROW, & HEMATOPOIETICSYS C420, C421, C424
PRECURSOR LYMPHOID NEOPLASMS 981 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9820/3 Lymphoid leukemia, NOS

9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
9826/3 Burkitt cell leukemia
9827/3 Adult T-cell leukemia/lymphoma (HTLV-1 pos.)
9828/3 Acute lymphoblastic leukemia, L2 type, NOS

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9832/3 Prolymphocytic leukemia, NOS
9833/3 Prolymphocytic leukemia, B-cell type
9834/3 Prolymphocytic leukemia, T-cell type
9835/3 Precursor cell lymphoblastic leukemia, NOS
9836/3 Precursor B-cell lymphoblastic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

ERYTHROID LEUKEMIA 984 9840/3 Acute myeloid leukemia, M6 type

MYELOID LEUKEMIA, NOS 986 9860/3 Myeloid leukemia, NOS

9861/3 Acute myeloid leukemia
9863/3 Chronic myeloid leukemia, NOS
9865/3 Acute myeloid leukemia with t(6;9)(p23;q34) DEK-NUP214
9866/3 Acute promyelocytic leuk.,t(15;17)(q22;q11-12)
9867/3 Acute myelomonocytic leukemia
9869/3 Acute myeloid leukemia with inv(3)(q21q26.2) or
t(3;3)(q21;q26.2);RPN1EVI1

OTHER MYELOID LEUKEMIAS 987 9870/3 Acute basophilic leukemia

9871/3 Ac. myelomonocytic leuk. w abn. mar. eosinophils
9872/3 Acute myeloid leukemia, minimal differentiation
9873/3 Acute myeloid leukemia without maturation
9874/3 Acute myeloid leukemia with maturation
9875/3 Chronic myelogenous leukemia, BCR/ABL positive
9876/3 Atypical chronic myeloid leuk., BCR/ABL negative
9877/3 Acute myeloid leukemia with mutated NPM1
9878/3 Acute myeloid leukemia with biallelic mutations of CEBPA
9879/3 Acute myeloid leukemia with mutated RUNX1

MONOCYTIC/OTHER LEUKEMIA, NOS 989 9891/3 Acute monocytic leukemia

9895/3 Acute myeloid leuk. with multilineage dysplasia
9896/3 Acute myeloid leukemia, t(8;21)(q22;q22)
9897/3 Acute myeloid leukemia, 11q23 abnormalities
9898/3 Myeloid leukemia associated with Down Syndrome
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 191
BLOOD, BONE MARROW, & HEMATOPOIETICSYS C420, C421, C424
MEGAKARYOBLASTIC LEUKEMIA 991 9910/3 Acute megakaryoblastic leukemia
9911/3 Acute myeloid leukemia (megakaryoblastic) with
t(1;22)(p13;q13);RBM15-MLK1
9912/3 Acute myeloid leukemia with BCR-ABL1

THERAPY RELATED AC. MYEL. LEUK. 992 9920/3 Therapy-related acute myeloid leukemia, NOS

MYELOID SARCOMA 993 9930/3 Myeloid sarcoma

9931/3 Acute panmyelosis with myelofibrosis

OTHER LEUKEMIAS 994 9940/3 Hairy cell leukemia

9945/3 Chronic myelomonocytic leukemia, NOS
9946/3 Juvenile myelomonocytic leukemia
9948/3 Aggressive NK-cell leukemia

POLYCYTHEMIA VERA 995 9950/3 Polycythemia vera

CHRONIC MYELOPROLIFERATIVE DIS. 996 9960/3 Chronic myeloproliferative disease, NOS

9961/3 Myelosclerosis with myeloid metaplasia
9962/3 Essential thrombocythemia
9963/3 Chronic neutrophilic leukemia
9964/3 Hypereosinophilic syndrome
9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable

REFRACTORY ANEMIA 998 9980/3 Refractory anemia

9982/3 Refractory anemia with sideroblasts
9983/3 Refractory anemia with excess blasts
9984/3 Refract. anemia with excess blasts in transformation
9985/3 Refractory cytopenia with multilineage dysplasia
9986/3 Myelodysplastic syndr. with 5q deletion syndrome
9987/3 Therapy-related myelodysplastic syndrome, NOS
9989/3 Myelodysplastic syndrome, NOS

MYELODYSPLASTIC SYNDROMES 999 9991/3 Refractory neutropenia

9992/3 Refractory thrombocytopenia
9993/3 Myelodysplastic syndrome with ring sideroblasts and multilineage
dysplasia
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 192
SPLEEN C422
BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
9678/3 Primary effusion lymphoma
9679/3 Mediastinal large B-cell lymphoma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
9689/3 Splenic marginal zone B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 193
SPLEEN C422
OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 194
SPLEEN C422
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 195
RETICULO-ENDOTHELIAL C423
MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 196
SKIN C440-C449
TRICHILEMMOCARCINOMA 810 8102/3 Trichilemmocarcinoma

PILOMATRIX CARCINOMA 811 8110/3 Pilomatrix carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8247/3 Merkel cell carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

SKIN APPENDAGE CARCINOMA 839 8390/3 Skin appendage carcinoma

SWEAT GLAND ADENOCARCINOMA 840 8400/3 Sweat gland adenocarcinoma

8401/3 Apocrine adenocarcinoma
8402/3 Nodular hidradenoma, malignant
8403/3 Malignant eccrine spiradenoma
8407/3 Sclerosing sweat duct carcinoma
8408/3 Eccrine papillary adenocarcinoma
8409/3 Eccrine poroma, malignant
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 197
SKIN C440-C449
SEBACEOUS/ECCRINE ADENOCA. 841 8410/3 Sebaceous adenocarcinoma
8413/3 Eccrine adenocarcinoma

CERUMINOUS ADENOCARCINOMA 842 8420/3 Ceruminous adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

PAGET DISEASE, EXTRAMAMMARY 854 8542/3 Paget disease, extramammary

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8740/3 Mal. melanoma in junctional nevus
8741/2 Precancerous melanosis, NOS
8741/3 Mal. melanoma in precan. melanosis
8742/2 Lentigo maligna
8742/3 Lentigo maligna melanoma
8743/2 Superficial spreading melanoma, in situ
8743/3 Superficial spreading melanoma
8744/3 Acral lentiginous melanoma, malig.
8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

MAL. MELAN. IN GIANT PIGMT. NEVUS 876 8761/3 Mal. melanoma in giant pigmented nevus
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 198
SKIN C440-C449
EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

BLUE NEVUS, MALIGNANT 878 8780/3 Blue nevus, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

8832/3 Dermatofibrosarcoma, NOS
8833/3 Pigmented dermatofibrosarcoma protuberans

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 199
SKIN C440-C449
MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant

9133/3 Epithelioid hemangioendothelioma, malignant

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant

9561/3 MPNST with rhabdomyoblastic differentiation

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma
9597/3 Primary Cutaneous follicle centre lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 200
SKIN C440-C449
ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9700/3 Mycosis fungoides

9701/3 Sezary syndrome
9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
9708/3 Subcutaneous panniculitis-like T-cell lymphoma
9709/3 Cutaneous T-cell lymphoma, NOS

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9718/3 Primary cutan. CD30+ T-cell lymphoprolif. disorder

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9725/3 Hydroa vacciniforme-like lymphoma

9726/3 Primary Cutaneous gamma-delta T-cell lymphoma
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9751/3 Langerhans cell histiocytosis, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9837/3 T lymphoblastic leukemia/lymphoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 201
PERIPHERAL NERVES C470-C476,C478-C479
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

PARAGANGLIOMA 868 8680/3 Paraganglioma, malignant

EXTRA-ADRENAL PARAGANG., MAL 869 8693/3 Extra-adrenal paraganglioma, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

8832/3 Dermatofibrosarcoma, NOS
8833/3 Pigmented dermatofibrosarcoma protuberans

MYXOSARCOMA 884 8840/3 Myxosarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 202
PERIPHERAL NERVES C470-C476,C478-C479

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

SYNOVIAL SARCOMA, NOS 904 9040/3 Synovial sarcoma, NOS

9041/3 Synovial sarcoma, spindle cell
9042/3 Synovial sarcoma, epithelioid cell
9043/3 Synovial sarcoma, biphasic
9044/3 Clear cell sarcoma,NOS (except of kidney M-8964/3)

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant

9133/3 Epithelioid hemangioendothelioma, malignant

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

LYMPHANGIOSARCOMA 917 9170/3 Lymphangiosarcoma

OSSEOUS & CHONDROMATOUS NEOPLASMS 924 9240/3 Mesenchymal chondrosarcoma

9242/3 Clear cell chondrosarcoma
9243/3 Dedifferentiated chondrosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 203
PERIPHERAL NERVES C470-C476,C478-C479
GT. CELL TUMOR OF BONE, MAL. 925 9251/3 Malignant giant cell tumor of soft parts
9252/3 Malignant tenosynovial giant cell tumor

PERIPHERAL NEUROECTODERMAL TUMOR 936 9364/3 Peripheral neuroectodermal tumor

9365/3 Askin tumor

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

9542/3 Epithelioid malignant peripheral nerve sheath tumor

NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant

9561/3 MPNST with rhabdomyoblastic differentiation

PERINEURIOMA 957 9571/3 Perineurioma, malignant

GRANULAR CELL TUMOR 958 9580/3 Granular cell tumor, malignant

9581/3 Alveolar soft part sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 204
PERIPHERAL NERVES C470-C476,C478-C479
HODGKIN LYMPHOMA, NOD. SCLER. 966 9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
9708/3 Subcutaneous panniculitis-like T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9726/3 Primary Cutaneous gamma-delta T-cell lymphoma
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 205
PERIPHERAL NERVES C470-C476,C478-C479
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

MYELOID SARCOMA 993 9930/3 Myeloid sarcoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 206
RETROPERITONEUM & PERITONEUM C480-C482,C488
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

PAPILLARY SEROUS CYSTADENOCA 846 8460/3 Low-grade serous carcinoma

8461/3 High-grade serous carcinoma

PARAGANGLIOMA 868 8680/3 Paraganglioma, malignant

EXTRA-ADRENAL PARAGANG., MAL 869 8693/3 Extra-adrenal paraganglioma, malignant

GLOMANGIOSARCOMA 871 8714/3 PEComa, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYXOSARCOMA 884 8840/3 Myxosarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 207
RETROPERITONEUM & PERITONEUM C480-C482,C488
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

STROMAL SARCOMA 893 8930/3 Endometrial stromal sarcoma

8931/3 Endometrial stromal sarcoma, low grade
8936/3 Gastrointestinal stromal sarcoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

MESOTHELIOMA 905 9050/2 Mesothelioma, in situ

9050/3 Mesothelioma, malignant
9051/3 Fibrous mesothelioma, malignant
9052/3 Epithel. mesothelioma, mal.
9053/3 Mesothelioma, biphasic, malignant

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 208
RETROPERITONEUM & PERITONEUM C480-C482,C488
MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant

9133/3 Epithelioid hemangioendothelioma, malignant

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant

9561/3 MPNST with rhabdomyoblastic differentiation

PERINEURIOMA 957 9571/3 Perineurioma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 209
RETROPERITONEUM & PERITONEUM C480-C482,C488
ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 210
RETROPERITONEUM & PERITONEUM C480-C482,C488
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

MYELOID SARCOMA 993 9930/3 Myeloid sarcoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 211
CONNECTIVE & SOFT TISSUE C490-C496,C498-C499
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

PARAGANGLIOMA 868 8680/3 Paraganglioma, malignant

EXTRA-ADRENAL PARAGANG., MAL 869 8693/3 Extra-adrenal paraganglioma, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

8832/3 Dermatofibrosarcoma, NOS
8833/3 Pigmented dermatofibrosarcoma protuberans

MYXOSARCOMA 884 8840/3 Myxosarcoma

8842/3 Pulmonary myxoid sarcoma with EWSR1-CREB1 translocation

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma
8859/3 Myxoid pleomorphic liposarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 212
CONNECTIVE & SOFT TISSUE C490-C496,C498-C499
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8982/3 Myoepithelial carcinoma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

SYNOVIAL SARCOMA, NOS 904 9040/3 Synovial sarcoma, NOS

9041/3 Synovial sarcoma, spindle cell
9042/3 Synovial sarcoma, epithelioid cell
9043/3 Synovial sarcoma, biphasic
9044/3 Clear cell sarcoma,NOS (except of kidney M-8964/3)

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant

9133/3 Epithelioid hemangioendothelioma, malignant
9137/3 Intimal sarcoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 213
CONNECTIVE & SOFT TISSUE C490-C496,C498-C499
LYMPHANGIOSARCOMA 917 9170/3 Lymphangiosarcoma

OSSEOUS & CHONDROMATOUS NEOPLASMS 924 9240/3 Mesenchymal chondrosarcoma

9242/3 Clear cell chondrosarcoma
9243/3 Dedifferentiated chondrosarcoma

GT. CELL TUMOR OF BONE, MAL. 925 9251/3 Malignant giant cell tumor of soft parts
9252/3 Malignant tenosynovial giant cell tumor

PERIPHERAL NEUROECTODERMAL TUMOR 936 9364/3 Peripheral neuroectodermal tumor

9365/3 Askin tumor
9366/3 Round cell sarcoma with EWSR1-non-ETS fusions
9367/3 CIC-rearranged sarcoma
9368/3 Sarcoma with BCOR genetic alterations

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant

9561/3 MPNST with rhabdomyoblastic differentiation

PERINEURIOMA 957 9571/3 Perineurioma, malignant

GRANULAR CELL TUMOR 958 9580/3 Granular cell tumor, malignant

9581/3 Alveolar soft part sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 214
CONNECTIVE & SOFT TISSUE C490-C496,C498-C499
HODGKIN LYMPHOMA 965 9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
9708/3 Subcutaneous panniculitis-like T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9726/3 Primary Cutaneous gamma-delta T-cell lymphoma
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 215
CONNECTIVE & SOFT TISSUE C490-C496,C498-C499

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

MYELOID SARCOMA 993 9930/3 Myeloid sarcoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9966/3 Myeloid and lymphoid neoplasms with PDGFRB re arrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
9968/3 Myeloid/lymphoid neoplasm with PCM1-JAK2

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 216
BREAST C500-C506,C508-C509
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 217
BREAST C500-C506,C508-C509
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

ADENOCA. IN ADENOMA. POLYP 821 8211/3 Tubular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8251/3 Alveolar adenocarcinoma

8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS
8314/3 Lipid-rich carcinoma
8315/3 Glycogen-rich carcinoma

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

SWEAT GLAND ADENOCARCINOMA 840 8401/3 Apocrine adenocarcinoma

SEBACEOUS/ECCRINE ADENOCA. 841 8410/3 Sebaceous adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS CYSTADENOCARC., NOS 847 8470/3 Mucinous cystadenocarcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 218
BREAST C500-C506,C508-C509

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

DUCT CARCINOMA 850 8500/2 Intraductal carcinoma, noninfiltrating, NOS

8500/3 Invasive carcinoma of no special type
8501/2 Comedocarcinoma, non-infiltrating
8501/3 Comedocarcinoma, NOS
8502/3 Secretory carcinoma of breast
8503/2 Noninfiltrating intraductal papillary adenocarcinoma
8503/3 Intraductal papillary adenocarcinoma with invasion
8504/2 Noninfiltrating intracystic carcinoma
8504/3 Intracystic carcinoma, NOS
8507/2 Intraductal micropapillary carcinoma
8507/3 Invasive micropapillary carcinoma
8508/3 Cystic hypersecretory carcinoma
8509/2 Solid papillary carcinoma in situ
8509/3 Solid papillary carcinoma with invasion

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

8512/3 Medullary carcinoma with lymphoid stroma
8513/3 Atypical medullary carcinoma
8514/3 Duct carcinoma, desmoplastic type
8519/2 Pleomorphic lobular carcinoma in situ

LOBULAR AND OTHER DUCTAL CA. 852 8520/2 Lobular carcinoma in situ
8520/3 Lobular carcinoma, NOS
8521/3 Infiltrating ductular carcinoma
8522/2 Intraductal and lobular in situ carcinoma
8522/3 Infiltrating duct and lobular carcinoma
8523/2 Infiltr. duct mixed with other types of carcinoma, in situ
8523/3 Infiltr. duct mixed with other types of carcinoma
8524/3 Infiltrating lobular mixed with other types of carc.
8525/3 Polymorphous low grade adenocarcinoma

INFLAMMATORY CARCINOMA 853 8530/3 Inflammatory carcinoma

PAGET DISEASE, MAMMARY 854 8540/3 Paget disease, mammary

8541/3 Paget dis. & infil. duct carcinoma
8543/3 Paget disease and intraductal ca.

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 219
BREAST C500-C506,C508-C509
ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma
8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

STROMAL SARCOMA 893 8935/3 Stromal sarcoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 220
BREAST C500-C506,C508-C509
CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS
8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma
8983/3 Adenomyoepithelioma with carcinoma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

PHYLLODES TUMOR,MAL. 902 9020/3 Phyllodes tumor, malignant

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant

9133/3 Epithelioid hemangioendothelioma, malignant

GRANULAR CELL TUMOR 958 9580/3 Granular cell tumor, malignant

9581/3 Alveolar soft part sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 221
BREAST C500-C506,C508-C509
FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 222
BREAST C500-C506,C508-C509
PRECURSOR LYMPHOID NEOPLASMS 981 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 223
VAGINA & LABIA C510-C512,C518, C529
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/2 Sq. cell carcinoma, keratinizing, NOS, in situ
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8077/2 Squamous intraepithelial neoplasia, grade III
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
8085/3 Squamous cell carcinoma, HPV-positive
8086/3 Squamous cell carcinoma, HPV-negative
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 224
VAGINA & LABIA C510-C512,C518, C529
BASAL CELL CARCINOMA, NOS 809 8090/3 Basal cell carcinoma, NOS
8091/3 Multifocal superficial basal cell carcinoma
8092/3 Infiltrating basal cell carcinoma, NOS
8093/3 Basal cell carcinoma, fibroepithelial
8094/3 Basosquamous carcinoma
8095/3 Metatypical carcinoma
8097/3 Basal cell carcinoma, nodular
8098/3 Adenoid basal cell carcinoma

TRICHILEMMOCARCINOMA 810 8102/3 Trichilemmocarcinoma

PILOMATRIX CARCINOMA 811 8110/3 Pilomatrix carcinoma

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8323/3 Mixed cell adenocarcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 225
VAGINA & LABIA C510-C512,C518, C529
ENDOMETRIOID ADENOCARCINOMA 838 8380/3 Endometrioid carcinoma

SWEAT GLAND ADENOCARCINOMA 840 8401/3 Apocrine adenocarcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma
8482/3 Mucinous adenocarcinoma, endocervical type
8483/3 Adenocarcinoma, HPV-associated

PAGET DISEASE, EXTRAMAMMARY 854 8542/3 Paget disease, extramammary

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8740/3 Mal. melanoma in junctional nevus
8741/2 Precancerous melanosis, NOS
8741/3 Mal. melanoma in precan. melanosis
8742/2 Lentigo maligna
8742/3 Lentigo maligna melanoma
8743/3 Superficial spreading melanoma
8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

MAL. MELAN. IN GIANT PIGMT. NEVUS 876 8761/3 Mal. melanoma in giant pigmented nevus

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 226
VAGINA & LABIA C510-C512,C518, C529
SARCOMA, NOS 880 8800/3 Sarcoma, NOS
8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

8832/3 Dermatofibrosarcoma, NOS

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

STROMAL SARCOMA 893 8933/3 Adenosarcoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 227
VAGINA & LABIA C510-C512,C518, C529
CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS
8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

GERM CELL TUMORS 906 9064/3 Germinoma

EMBRYONAL CARCINOMA, NOS 907 9071/3 Yolk sac tumor

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma
9597/3 Primary Cutaneous follicle centre lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 228
VAGINA & LABIA C510-C512,C518, C529

T-CELL LYMPHOMAS 970 9700/3 Mycosis fungoides

9701/3 Sezary syndrome
9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
9708/3 Subcutaneous panniculitis-like T-cell lymphoma
9709/3 Cutaneous T-cell lymphoma, NOS

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9718/3 Primary cutan. CD30+ T-cell lymphoprolif. disorder
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9725/3 Hydroa vacciniforme-like lymphoma
9726/3 Primary Cutaneous gamma-delta T-cell lymphoma
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 229
VAGINA & LABIA C510-C512,C518, C529
PRECURSOR LYMPHOID NEOPLASMS 981 9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 230
VULVA, NOS C519
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/2 Sq. cell carcinoma, keratinizing, NOS, in situ
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8077/2 Squamous intraepithelial neoplasia, grade III
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
8085/3 Squamous cell carcinoma, HPV-positive
8086/3 Squamous cell carcinoma, HPV-negative
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 231
VULVA, NOS C519
BASAL CELL CARCINOMA, NOS 809 8090/3 Basal cell carcinoma, NOS
8091/3 Multifocal superficial basal cell carcinoma
8092/3 Infiltrating basal cell carcinoma, NOS
8093/3 Basal cell carcinoma, fibroepithelial
8094/3 Basosquamous carcinoma
8095/3 Metatypical carcinoma
8097/3 Basal cell carcinoma, nodular
8098/3 Adenoid basal cell carcinoma

TRICHILEMMOCARCINOMA 810 8102/3 Trichilemmocarcinoma

PILOMATRIX CARCINOMA 811 8110/3 Pilomatrix carcinoma

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

CARCINOID TUMOR, MALIGNANT 824 8247/3 Merkel cell carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 232
VULVA, NOS C519
GRANULAR CELL CARCINOMA 832 8323/3 Mixed cell adenocarcinoma

ENDOMETRIOID ADENOCARCINOMA 838 8380/3 Endometrioid carcinoma

SKIN APPENDAGE CARCINOMA 839 8390/3 Skin appendage carcinoma

SWEAT GLAND ADENOCARCINOMA 840 8400/3 Sweat gland adenocarcinoma

8401/3 Apocrine adenocarcinoma

SEBACEOUS/ECCRINE ADENOCA. 841 8410/3 Sebaceous adenocarcinoma

8413/3 Eccrine adenocarcinoma

CERUMINOUS ADENOCARCINOMA 842 8420/3 Ceruminous adenocarcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma
8482/3 Mucinous adenocarcinoma, endocervical type
8483/3 Adenocarcinoma, HPV-associated

PAGET DISEASE, EXTRAMAMMARY 854 8542/3 Paget disease, extramammary

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8740/3 Mal. melanoma in junctional nevus
8741/2 Precancerous melanosis, NOS
8741/3 Mal. melanoma in precan. melanosis
8742/2 Lentigo maligna
8742/3 Lentigo maligna melanoma
8743/3 Superficial spreading melanoma
8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 233
VULVA, NOS C519

MAL. MELAN. IN GIANT PIGMT. NEVUS 876 8761/3 Mal. melanoma in giant pigmented nevus

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

BLUE NEVUS, MALIGNANT 878 8780/3 Blue nevus, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

8832/3 Dermatofibrosarcoma, NOS

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 234
VULVA, NOS C519
RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS
8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

STROMAL SARCOMA 893 8933/3 Adenosarcoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

GERM CELL TUMORS 906 9064/3 Germinoma

EMBRYONAL CARCINOMA, NOS 907 9071/3 Yolk sac tumor

STRUMA OVARII, MALIGNANT 909 9092/3 Phyllodes tumor, malignant

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma
9597/3 Primary Cutaneous follicle centre lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 235
VULVA, NOS C519
ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9700/3 Mycosis fungoides

9701/3 Sezary syndrome
9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
9708/3 Subcutaneous panniculitis-like T-cell lymphoma
9709/3 Cutaneous T-cell lymphoma, NOS

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9718/3 Primary cutan. CD30+ T-cell lymphoprolif. disorder
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9725/3 Hydroa vacciniforme-like lymphoma
9726/3 Primary Cutaneous gamma-delta T-cell lymphoma
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 236
VULVA, NOS C519
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 237
CERVIX UTERI C530-C531,C538-C539
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/2 Sq. cell carcinoma, keratinizing, NOS, in situ
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/2 Sq. cell carcinoma, lg. cell, non-ker., in situ
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8077/2 Squamous intraepithelial neoplasia, grade III
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 238
CERVIX UTERI C530-C531,C538-C539
SQUAMOUS CELL CARCINOMA, NOS 807 8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
8085/3 Squamous cell carcinoma, HPV-positive
8086/3 Squamous cell carcinoma, HPV-negative

BASAL CELL CARCINOMA, NOS 809 8098/3 Adenoid basal cell carcinoma

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8323/3 Mixed cell adenocarcinoma

ENDOMETRIOID ADENOCARCINOMA 838 8380/3 Endometrioid carcinoma

8384/3 Adenocarcinoma, endocervical type

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 239
CERVIX UTERI C530-C531,C538-C539
MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma
8481/3 Mucin-producing adenocarcinoma
8482/3 Mucinous adenocarcinoma, endocervical type
8483/3 Adenocarcinoma, HPV-associated
8484/3 Adenocarcinoma, HPV-independent, NOS

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

STROMAL SARCOMA 893 8933/3 Adenosarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 240
CERVIX UTERI C530-C531,C538-C539
MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor
8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

GERM CELL TUMORS 906 9064/3 Germinoma

EMBRYONAL CARCINOMA, NOS 907 9071/3 Yolk sac tumor

CHORIOCARCINOMA 910 9100/3 Choriocarcinoma

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 241
CERVIX UTERI C530-C531,C538-C539
FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 242
CERVIX UTERI C530-C531,C538-C539
PRECURSOR LYMPHOID NEOPLASMS 981 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 243
CORPUS UTERI C540-C543,C548-C549
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 244
CORPUS UTERI C540-C543,C548-C549
TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8144/3 Adenocarcinoma, intestinal type
8147/3 Basal cell adenocarcinoma

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8211/3 Tubular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

ENDOMETRIOID ADENOCARCINOMA 838 8380/2 Endometrioid intraepithelial neoplasia

8380/3 Endometrioid carcinoma
8381/3 Endometrioid adenofibroma, malignant
8382/3 Endometrioid adenocarcinoma, secretory variant
8383/3 Endometrioid adenocarcinoma, ciliated cell variant
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 245
CORPUS UTERI C540-C543,C548-C549
CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS
8441/2 Serous tubal intraepithelial carcinoma
8441/3 Serous cystadenocarcinoma

PAPILLARY SEROUS CYSTADENOCA 846 8460/3 Low-grade serous carcinoma

8461/3 High-grade serous carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma
8482/3 Mucinous adenocarcinoma, endocervical type

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

GLOMANGIOSARCOMA 871 8714/3 PEComa, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 246
CORPUS UTERI C540-C543,C548-C549

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

STROMAL SARCOMA 893 8930/3 Endometrial stromal sarcoma

8931/3 Endometrial stromal sarcoma, low grade
8933/3 Adenosarcoma
8934/3 Carcinofibroma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

GERM CELL TUMORS 906 9064/3 Germinoma

EMBRYONAL CARCINOMA, NOS 907 9071/3 Yolk sac tumor

TERATOMA 908 9080/3 Teratoma, malignant, NOS

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

9111/3 Mesonephric-like adenocarcinoma

MEDULLOBLASTOMA, NOS 947 9473/3 Primitive neuroectodermal tumor

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 247
CORPUS UTERI C540-C543,C548-C549
HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]
9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 248
CORPUS UTERI C540-C543,C548-C549
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 249
UTERUS, NOS C559
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 250
UTERUS, NOS C559
LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8211/3 Tubular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 251
UTERUS, NOS C559
GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma
8323/3 Mixed cell adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

8441/2 Serous tubal intraepithelial carcinoma
8441/3 Serous cystadenocarcinoma

PAPILLARY SEROUS CYSTADENOCA 846 8460/3 Low-grade serous carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma
8482/3 Mucinous adenocarcinoma, endocervical type

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
8576/3 Hepatoid adenocarcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 252
UTERUS, NOS C559
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

STROMAL SARCOMA 893 8930/3 Endometrial stromal sarcoma

8931/3 Endometrial stromal sarcoma, low grade
8934/3 Carcinofibroma
8935/3 Stromal sarcoma, NOS

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 253
UTERUS, NOS C559
HODGKIN LYMPHOMA, NOD. SCLER. 966 9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 254
UTERUS, NOS C559
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 255
OVARY C569
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8044/3 Small cell carcinoma, intermediate cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 256
OVARY C569
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS
8313/3 Clear cell adenocarcinofibroma

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

ENDOMETRIOID ADENOCARCINOMA 838 8380/3 Endometrioid carcinoma

8381/3 Endometrioid adenofibroma, malignant
8382/3 Endometrioid adenocarcinoma, secretory variant
8383/3 Endometrioid adenocarcinoma, ciliated cell variant

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

8441/2 Serous tubal intraepithelial carcinoma
8441/3 Serous cystadenocarcinoma
8442/1 Serous cystadenoma, borderline malignancy (C56.9)
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 257
OVARY C569
PAPILLARY CYSTADENOCA., NOS 845 8450/3 Papillary cystadenocarcinoma, NOS
8451/1 Papillary cystadenoma, borderline malignancy (C56.9)

PAPILLARY SEROUS CYSTADENOCA 846 8460/2 Non-invasive low grade serous carcinoma
8460/3 Low-grade serous carcinoma
8461/3 High-grade serous carcinoma
8462/1 Serous papillary cystic tumor of borderline malignancy (C56.9)

MUCINOUS CYSTADENOCARC., NOS 847 8470/2 Mucinous cystadenocarcinoma, non-invasive

8470/3 Mucinous cystadenocarcinoma, NOS
8471/3 Papillary mucinous cystadenocarcinoma
8472/1 Mucinous cystic tumor of borderline malignancy (C56.9)
8473/1 Papillary mucinous cystadenoma, borderline malignancy (C56.9)
8474/3 Seromucinous carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma
8482/3 Mucinous adenocarcinoma, endocervical type

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

OVARIAN STROMAL TUMOR, MAL. 859 8590/3 Ovarian stromal tumor, mal.

THECOMA, MALIGNANT 860 8600/3 Thecoma, malignant

GRANULOSA CELL TUMOR, MAL. 862 8620/3 Granulosa cell tumor, malignant
8621/3 Granulosa cell-theca cell tumor, mal.

GONADAL NEOPLASMS 863 8630/3 Androblastoma, malignant

8631/3 Sertoli-Leydig cell tumor, poorly differentiated
8632/3 Gynandroblastoma, malignant
8634/3 Sertoli-Leydig cl tum., p.d. w heterologous elements

LIPID CELL TUMOR, MAL. 867 8670/3 Steroid cell tumor, malignant
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 258
OVARY C569
SARCOMA, NOS 880 8800/3 Sarcoma, NOS
8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

MYXOSARCOMA 884 8840/3 Myxosarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

STROMAL SARCOMA 893 8930/3 Endometrial stromal sarcoma

8931/3 Endometrial stromal sarcoma, low grade
8933/3 Adenosarcoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

BRENNER TUMOR, MALIGNANT 900 9000/3 Brenner tumor, malignant

ADENOCARCINOFIBROMA 901 9014/3 Serous adenocarcinofibroma

9015/3 Mucinous adenocarcinofibroma

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 259
OVARY C569
EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS
9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

STRUMA OVARII, MALIGNANT 909 9090/3 Struma ovarii, malignant

CHORIOCARCINOMA 910 9100/3 Choriocarcinoma

9101/3 Choriocarcinoma combined w/ other germ cell elements
9105/3 Trophoblastic tumor, epithelioid

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

9111/3 Mesonephric-like adenocarcinoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 260
OVARY C569
ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 261
OVARY C569
PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS
9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 262
FALLOPIANTUBE C570
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 263
FALLOPIANTUBE C570
BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8323/3 Mixed cell adenocarcinoma

ENDOMETRIOID ADENOCARCINOMA 838 8380/3 Endometrioid carcinoma

8382/3 Endometrioid adenocarcinoma, secretory variant
8383/3 Endometrioid adenocarcinoma, ciliated cell variant

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

8441/2 Serous tubal intraepithelial carcinoma
8441/3 Serous cystadenocarcinoma

PAPILLARY SEROUS CYSTADENOCA 846 8460/3 Low-grade serous carcinoma

8461/3 High-grade serous carcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma
8482/3 Mucinous adenocarcinoma, endocervical type

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 264
FALLOPIANTUBE C570
FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS
8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

STROMAL SARCOMA 893 8933/3 Adenosarcoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 265
FALLOPIANTUBE C570
ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 266
FALLOPIANTUBE C570
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 267
OTHER FEMALE GENITAL (EXCL FALLOPIANTUBE) C571-C574,C577-C579
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 268
OTHER FEMALE GENITAL (EXCL FALLOPIANTUBE) C571-C574,C577-C579
BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8323/3 Mixed cell adenocarcinoma

ENDOMETRIOID ADENOCARCINOMA 838 8380/3 Endometrioid carcinoma

8382/3 Endometrioid adenocarcinoma, secretory variant
8383/3 Endometrioid adenocarcinoma, ciliated cell variant

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma
8482/3 Mucinous adenocarcinoma, endocervical type

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 269
OTHER FEMALE GENITAL (EXCL FALLOPIANTUBE) C571-C574,C577-C579
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 270
OTHER FEMALE GENITAL (EXCL FALLOPIANTUBE) C571-C574,C577-C579
FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 271
OTHER FEMALE GENITAL (EXCL FALLOPIANTUBE) C571-C574,C577-C579
PRECURSOR LYMPHOID NEOPLASMS 981 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 272
PLACENTA C589
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CHORIOCARCINOMA 910 9100/3 Choriocarcinoma

9101/3 Choriocarcinoma combined w/ other germ cell elements
9104/3 Malignant placental site trophoblastic tumor
9105/3 Trophoblastic tumor, epithelioid

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 273
PENIS C600-C602,C608-C609
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma
8054/3 Warty carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/2 Sq. cell carcinoma, keratinizing, NOS, in situ
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8080/2 Queyrat erythroplasia

8081/2 Bowen disease
8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 274
PENIS C600-C602,C608-C609
BASAL CELL CARCINOMA, NOS 809 8090/3 Basal cell carcinoma, NOS
8091/3 Multifocal superficial basal cell carcinoma
8092/3 Infiltrating basal cell carcinoma, NOS
8093/3 Basal cell carcinoma, fibroepithelial
8094/3 Basosquamous carcinoma
8095/3 Metatypical carcinoma
8097/3 Basal cell carcinoma, nodular
8098/3 Adenoid basal cell carcinoma

TRICHILEMMOCARCINOMA 810 8102/3 Trichilemmocarcinoma

PILOMATRIX CARCINOMA 811 8110/3 Pilomatrix carcinoma

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

SKIN APPENDAGE CARCINOMA 839 8390/3 Skin appendage carcinoma

SWEAT GLAND ADENOCARCINOMA 840 8400/3 Sweat gland adenocarcinoma

8401/3 Apocrine adenocarcinoma

SEBACEOUS/ECCRINE ADENOCA. 841 8410/3 Sebaceous adenocarcinoma

8413/3 Eccrine adenocarcinoma

PAGET DISEASE, EXTRAMAMMARY 854 8542/3 Paget disease, extramammary

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 275
PENIS C600-C602,C608-C609
ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia
8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8740/3 Mal. melanoma in junctional nevus
8741/2 Precancerous melanosis, NOS
8741/3 Mal. melanoma in precan. melanosis
8742/2 Lentigo maligna
8742/3 Lentigo maligna melanoma
8743/3 Superficial spreading melanoma
8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

MAL. MELAN. IN GIANT PIGMT. NEVUS 876 8761/3 Mal. melanoma in giant pigmented nevus

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

BLUE NEVUS, MALIGNANT 878 8780/3 Blue nevus, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 276
PENIS C600-C602,C608-C609

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

MALIGNANT LYMPHOMA, NOS 959 9597/3 Primary Cutaneous follicle centre lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 277
PENIS C600-C602,C608-C609
T-CELL LYMPHOMAS 970 9700/3 Mycosis fungoides
9701/3 Sezary syndrome
9708/3 Subcutaneous panniculitis-like T-cell lymphoma
9709/3 Cutaneous T-cell lymphoma, NOS

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9718/3 Primary cutan. CD30+ T-cell lymphoprolif. disorder

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9725/3 Hydroa vacciniforme-like lymphoma

9726/3 Primary Cutaneous gamma-delta T-cell lymphoma

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 278
PROSTATE GLAND C619
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 279
PROSTATE GLAND C619
TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma
8148/2 Glandular intraepithelial neoplasia, grade III

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

ADENOCA. IN ADENOMA. POLYP 821 8211/3 Tubular adenocarcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8251/3 Alveolar adenocarcinoma

8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

DUCT CARCINOMA 850 8500/2 Intraductal carcinoma, noninfiltrating, NOS

8500/3 Invasive carcinoma of no special type
8503/2 Noninfiltrating intraductal papillary adenocarcinoma
8503/3 Intraductal papillary adenocarcinoma with invasion
8504/2 Noninfiltrating intracystic carcinoma
8504/3 Intracystic carcinoma, NOS
8507/2 Intraductal micropapillary carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 280
PROSTATE GLAND C619
MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS
8514/3 Duct carcinoma, desmoplastic type

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma
8552/3 Mixed acinar ductal carcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 281
PROSTATE GLAND C619
ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma
8921/3 Rhabdomyosarcoma with ganglionic differentiation

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

ML, LARGE B-CELL, DIFFUSE 968 9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9715/3 Anaplastic large cell lymphoma, ALK negative

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood

PLASMA CELL TUMORS 973 9735/3 Plasmablastic lymphoma

9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9751/3 Langerhans cell histiocytosis, NOS
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 282
PROSTATE GLAND C619
MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD
9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 283
TESTIS C620-C621,C629
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

GONADAL NEOPLASMS 863 8630/3 Androblastoma, malignant

8631/3 Sertoli-Leydig cell tumor, poorly differentiated
8634/3 Sertoli-Leydig cl tum., p.d. w heterologous elements

SERTOLI CELL CARCINOMA 864 8640/3 Sertoli cell carcinoma

LEYDIG CELL TUMOR, MALIGNANT 865 8650/3 Leydig cell tumor, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 284
TESTIS C620-C621,C629
SARCOMA, NOS 880 8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9061/3 Seminoma, NOS
9062/3 Seminoma, anaplastic
9063/3 Spermatocytic seminoma
9064/2 Intratubular malignant germ cells
9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

CHORIOCARCINOMA 910 9100/3 Choriocarcinoma

9101/3 Choriocarcinoma combined w/ other germ cell elements
9102/3 Malignant teratoma, trophoblastic
9105/3 Trophoblastic tumor, epithelioid

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 285
TESTIS C620-C621,C629
HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]
9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 286
TESTIS C620-C621,C629
MAST CELL TUMORS 974 9740/3 Mast cell sarcoma
9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 287
EPIDIDYMIS, SPERMATICCORD, MALE GENITAL, NOS C630, C631, C637-C639
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 288
EPIDIDYMIS, SPERMATICCORD, MALE GENITAL, NOS C630, C631, C637-C639
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

SWEAT GLAND ADENOCARCINOMA 840 8401/3 Apocrine adenocarcinoma

PAGET DISEASE, EXTRAMAMMARY 854 8542/3 Paget disease, extramammary

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 289
EPIDIDYMIS, SPERMATICCORD, MALE GENITAL, NOS C630, C631, C637-C639
LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS
8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 290
SCROTUM C632
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8080/2 Queyrat erythroplasia

8081/2 Bowen disease
8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

BASAL CELL CARCINOMA, NOS 809 8090/3 Basal cell carcinoma, NOS
8091/3 Multifocal superficial basal cell carcinoma
8092/3 Infiltrating basal cell carcinoma, NOS
8093/3 Basal cell carcinoma, fibroepithelial
8094/3 Basosquamous carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 291
SCROTUM C632
BASAL CELL CARCINOMA, NOS 809 8095/3 Metatypical carcinoma
8097/3 Basal cell carcinoma, nodular
8098/3 Adenoid basal cell carcinoma

TRICHILEMMOCARCINOMA 810 8102/3 Trichilemmocarcinoma

PILOMATRIX CARCINOMA 811 8110/3 Pilomatrix carcinoma

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

SKIN APPENDAGE CARCINOMA 839 8390/3 Skin appendage carcinoma

SWEAT GLAND ADENOCARCINOMA 840 8400/3 Sweat gland adenocarcinoma

8401/3 Apocrine adenocarcinoma

SEBACEOUS/ECCRINE ADENOCA. 841 8410/3 Sebaceous adenocarcinoma

8413/3 Eccrine adenocarcinoma

PAGET DISEASE, EXTRAMAMMARY 854 8542/3 Paget disease, extramammary

ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia

8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 292
SCROTUM C632
NEVI & MELANOMAS 872 8720/2 Melanoma in situ
8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8740/3 Mal. melanoma in junctional nevus
8741/2 Precancerous melanosis, NOS
8741/3 Mal. melanoma in precan. melanosis
8742/2 Lentigo maligna
8742/3 Lentigo maligna melanoma
8743/3 Superficial spreading melanoma
8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

MAL. MELAN. IN GIANT PIGMT. NEVUS 876 8761/3 Mal. melanoma in giant pigmented nevus

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

BLUE NEVUS, MALIGNANT 878 8780/3 Blue nevus, malignant

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 293
SCROTUM C632
LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS
8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

MALIGNANT LYMPHOMA, NOS 959 9597/3 Primary Cutaneous follicle centre lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9700/3 Mycosis fungoides

9701/3 Sezary syndrome
9708/3 Subcutaneous panniculitis-like T-cell lymphoma
9709/3 Cutaneous T-cell lymphoma, NOS

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9718/3 Primary cutan. CD30+ T-cell lymphoprolif. disorder
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 294
SCROTUM C632

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9725/3 Hydroa vacciniforme-like lymphoma

9726/3 Primary Cutaneous gamma-delta T-cell lymphoma

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 295
KIDNEY C649
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 296
KIDNEY C649
TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

ADENOCA. IN ADENOMA. POLYP 821 8211/3 Tubular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS
8311/3 Hereditary leiomyomatosis and RCC-associated renal cell carcinoma
8312/3 Renal cell carcinoma
8316/3 Cyst-associated renal cell carcinoma
8317/3 Renal cell carcinoma, chromophobe type
8318/3 Renal cell carcinoma, sarcomatoid
8319/3 Collecting duct carcinoma

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 297
KIDNEY C649
MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma
8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 298
KIDNEY C649
MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor
8951/3 Mesodermal mixed tumor
8959/3 Malignant cystic nephroma

CLEAR CELL SARC/NEPHROBLASTOMA 896 8960/3 Nephroblastoma, NOS

8963/3 Malignant rhabdoid tumor
8964/3 Clear cell sarcoma of kidney

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 299
KIDNEY C649
ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 300
KIDNEY C649
PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS
9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 301
RENAL PELVIS, URETER C659, C669
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 302
RENAL PELVIS, URETER C659, C669
TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

ADENOCA. IN ADENOMA. POLYP 821 8211/3 Tubular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 303
RENAL PELVIS, URETER C659, C669
SARCOMA, NOS 880 8800/3 Sarcoma, NOS
8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor
8959/3 Malignant cystic nephroma

CLEAR CELL SARC/NEPHROBLASTOMA 896 8964/3 Clear cell sarcoma of kidney

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 304
RENAL PELVIS, URETER C659, C669
CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS
8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 305
RENAL PELVIS, URETER C659, C669
FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 306
RENAL PELVIS, URETER C659, C669
PRECURSOR LYMPHOID NEOPLASMS 981 9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 307
URINARYBLADDER C670-C679
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 308
URINARYBLADDER C670-C679
TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ADENOCA. WITH METAPLASIA 857 8576/3 Hepatoid adenocarcinoma

PARAGANGLIOMA 868 8680/3 Paraganglioma, malignant

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 309
URINARYBLADDER C670-C679
SARCOMA, NOS 880 8800/3 Sarcoma, NOS
8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 310
URINARYBLADDER C670-C679
MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS
9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 311
URINARYBLADDER C670-C679
PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 312
OTHER URINARYORGANS C680-C681,C688-C689
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 313
OTHER URINARYORGANS C680-C681,C688-C689
TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

ENDOMETRIOID ADENOCARCINOMA 838 8380/3 Endometrioid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 314
OTHER URINARYORGANS C680-C681,C688-C689
ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma
8562/3 Epithelial-myoepithelial carcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 315
OTHER URINARYORGANS C680-C681,C688-C689
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CLEAR CELL SARC/NEPHROBLASTOMA 896 8964/3 Clear cell sarcoma of kidney

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 316
OTHER URINARYORGANS C680-C681,C688-C689
MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS
9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 317
OTHER URINARYORGANS C680-C681,C688-C689
PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 318
ORBIT & LACRIMALGLAND, (EXCL. RETINA, EYE, NOS) C690-C691, C693, C695-C698
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 319
ORBIT & LACRIMALGLAND, (EXCL. RETINA, EYE, NOS) C690-C691, C693, C695-C698

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS
8773/3 Spindle cell melanoma, type A
8774/3 Spindle cell melanoma, type B

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 320
ORBIT & LACRIMALGLAND, (EXCL. RETINA, EYE, NOS) C690-C691, C693, C695-C698
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 321
ORBIT & LACRIMALGLAND, (EXCL. RETINA, EYE, NOS) C690-C691, C693, C695-C698
ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 322
ORBIT & LACRIMALGLAND, (EXCL. RETINA, EYE, NOS) C690-C691, C693, C695-C698
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 323
RETINA C692
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 324
RETINA C692

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 325
RETINA C692
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

RETINOBLASTOMA, NOS 951 9510/3 Retinoblastoma, NOS

9511/3 Retinoblastoma, differentiated
9512/3 Retinoblastoma, undifferentiated
9513/3 Retinoblastoma, diffuse

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 326
RETINA C692

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 327
RETINA C692
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 328
EYEBALL C694
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

LYMPHOEPITHELIAL CARCINOMA 808 8081/2 Bowen disease

8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 329
EYEBALL C694

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS
8773/3 Spindle cell melanoma, type A
8774/3 Spindle cell melanoma, type B

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 330
EYEBALL C694
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 331
EYEBALL C694
ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 332
EYEBALL C694
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 333
EYE, NOS C699
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 334
EYE, NOS C699
PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

NEVI & MELANOMAS 872 8720/2 Melanoma in situ

8720/3 Malignant melanoma, NOS
8721/3 Nodular melanoma
8722/3 Balloon cell melanoma
8723/3 Malignant melanoma, regressing

AMELANOTIC MELANOMA 873 8730/3 Amelanotic melanoma

MAL. MEL. IN JUNCT. NEVUS 874 8743/3 Superficial spreading melanoma

8745/3 Desmoplastic melanoma, malignant
8746/3 Mucosal lentiginous melanoma

EPITHELIOID CELL MELANOMA 877 8770/3 Mixed epithel. & spindle cell melanoma
8771/3 Epithelioid cell melanoma
8772/3 Spindle cell melanoma, NOS

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 335
EYE, NOS C699
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

RETINOBLASTOMA, NOS 951 9510/3 Retinoblastoma, NOS

9511/3 Retinoblastoma, differentiated
9512/3 Retinoblastoma, undifferentiated
9513/3 Retinoblastoma, diffuse

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 336
EYE, NOS C699

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 337
EYE, NOS C699
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 338
MENINGES (CEREBRAL,SPINAL) C700-C701,C709
NEOPLASM 800 8000/0 Neoplasm, benign
8000/1 Neoplasm, uncertain whether benign or malignant
8000/3 Neoplasm, malignant
8001/0 Tumor cells, benign
8001/1 Tumor cells, uncertain whether benign or malignant
8001/3 Tumor cells, malignant
8005/3 Malignant tumor, clear cell type

NEVI & MELANOMAS 872 8720/3 Malignant melanoma, NOS

8728/0 Diffuse melanocytosis
8728/1 Meningeal melanocytoma
8728/3 Meningeal melanomatosis

SARCOMA, NOS 880 8800/0 Soft tissue tumor, benign

8800/3 Sarcoma, NOS
8801/3 Spindle cell sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/0 Fibroma, NOS

8810/3 Fibrosarcoma, NOS
8815/0 Solitary fibrous tumor

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

LIPOSARCOMA NEOPLASMS 885 8850/0 Lipoma, NOS

8851/0 Fibrolipoma

ANGIOLIPOMA 886 8861/0 Angiolipoma, NOS

MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

TERATOMA 908 9080/0 Teratoma, benign

9080/1 Teratoma, NOS
9080/3 Teratoma, malignant, NOS
9084/0 Dermoid cyst, NOS
9084/3 Teratoma with malig. transformation

BLOOD VESSEL TUMORS 912 9120/0 Hemangioma, NOS

9121/0 Cavernous hemangioma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 339
MENINGES (CEREBRAL,SPINAL) C700-C701,C709
HEMANGIOPERICYTOMA 915 9150/0 Hemangiopericytoma, benign
9150/1 Hemangiopericytoma, NOS
9150/3 Hemangiopericytoma, malignant

HEMANGIOBLASTOMA 916 9161/1 Hemangioblastoma

OSSEOUS & CHONDROMATOUS NEOPLASMS 924 9240/3 Mesenchymal chondrosarcoma

MENINGIOMA 953 9530/0 Meningioma, NOS

9530/1 Meningiomatosis, NOS
9530/3 Meningioma, malignant
9531/0 Meningothelial meningioma
9532/0 Fibrous meningioma
9533/0 Psammomatous meningioma
9534/0 Angiomatous meningioma
9537/0 Transitional meningioma
9538/1 Clear cell meningioma
9538/3 Papillary meningioma
9539/1 Atypical meningioma
9539/3 Meningeal sarcomatosis

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 340
MENINGES (CEREBRAL,SPINAL) C700-C701,C709
ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 341
MENINGES (CEREBRAL,SPINAL) C700-C701,C709
PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS
9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 342
BRAIN, & CRANIALNERVES, & SPINAL CORD, (EXCL. VENTRICLE, CEREBELLUM) C710-C714, C717-C719, C720-C725
NEOPLASM 800 8000/0 Neoplasm, benign
8000/1 Neoplasm, uncertain whether benign or malignant
8000/3 Neoplasm, malignant
8001/0 Tumor cells, benign
8001/1 Tumor cells, uncertain whether benign or malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

PARAGANGLIOMA 868 8680/1 Paraganglioma, NOS

NEVI & MELANOMAS 872 8720/3 Malignant melanoma, NOS

SARCOMA, NOS 880 8800/0 Soft tissue tumor, benign

8800/3 Sarcoma, NOS
8801/3 Spindle cell sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8815/1 Solitary fibrous tumor/hemangiopericytoma Grade 2

8815/3 Hemangiopericytoma, malignant

LIPOSARCOMA NEOPLASMS 885 8850/0 Lipoma, NOS

8851/0 Fibrolipoma
8851/3 Liposarcoma, well differentiated

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor

TERATOMA 908 9080/0 Teratoma, benign

9080/1 Teratoma, NOS
9080/3 Teratoma, malignant, NOS
9081/3 Teratocarcinoma
9085/3 Mixed germ cell tumor

CHORIOCARCINOMA 910 9100/3 Choriocarcinoma

BLOOD VESSEL TUMORS 912 9120/0 Hemangioma, NOS

9121/0 Cavernous hemangioma
9122/0 Venous hemangioma

HEMANGIOENDOTHELIOMA 913 9131/0 Capillary hemangioma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 343
BRAIN, & CRANIALNERVES, & SPINAL CORD, (EXCL. VENTRICLE, CEREBELLUM) C710-C714, C717-C719, C720-C725

HEMANGIOPERICYTOMA 915 9150/1 Hemangiopericytoma, NOS

HEMANGIOBLASTOMA 916 9161/1 Hemangioblastoma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GLIOMA 938 9380/3 Glioma, malignant

9381/3 Gliomatosis cerebri
9382/3 Mixed glioma
9383/1 Subependymoma
9384/1 Supependymal giant cell astrocytoma
9385/3 Diffuse midline glioma, H3 K27M-mutant

EPENDYMOMA, NOS 939 9391/1 Sellar ependymoma

9391/3 Ependymoma, NOS
9392/3 Ependymoma, anaplastic
9393/3 Papillary ependymoma
9394/1 Myxopapillary ependymoma
9396/3 Ependymoma, RELA fusion-positive

ASTROCYTOMA, NOS 940 9400/3 Astrocytoma, NOS

9401/3 Astrocytoma, anaplastic

PROTOPLASMIC ASTROCYTOMA 941 9410/3 Protoplasmic astrocytoma

9411/3 Gemistocytic astrocytoma
9412/1 Desmoplastic infantile astrocytoma
9413/0 Dysembryoplastic neuroepithelial tumor

FIBRILLARY ASTROCYTOMA 942 9420/3 Fibrillary astrocytoma

9421/1 Pilocytic astrocytoma
9421/3 Pilocytic astrocytoma
9423/3 Polar spongioblastoma
9424/3 Pleomorphic xanthoastrocytoma
9425/3 Pilomyxoid astrocytoma

ASTROBLASTOMA 943 9430/3 Astroblastoma

9431/1 Angiocentric glioma

GLIOBLASTOMA, NOS 944 9440/3 Glioblastoma, NOS

9441/3 Giant cell glioblastoma
9442/1 Gliofibroma
9442/3 Gliosarcoma
9444/1 Chordoid glioma
9445/3 Glioblastoma, IDH-mutant
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 344
BRAIN, & CRANIALNERVES, & SPINAL CORD, (EXCL. VENTRICLE, CEREBELLUM) C710-C714, C717-C719, C720-C725

OLIGODENDROGLIOMA, NOS 945 9450/3 Oligodendroglioma, NOS

9451/3 Oligodendroglioma, anaplastic

OLIGODENDROBLASTOMA 946 9460/3 Oligodendroblastoma

MEDULLOBLASTOMA, NOS 947 9473/3 Primitive neuroectodermal tumor

9475/3 Medulloblastoma, WNT-activated
9476/3 Medulloblastoma, SHH-activated and TP53-mutant
9477/3 Medulloblastoma, non-WNT/non-SHH
9478/3 Embryonal tumor with multilayered rosettes, NOS

GANGLIONEUROBLASTOMA 949 9490/0 Ganglioneuroma

9490/3 Ganglioneuroblastoma
9492/0 Gangliocytoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9505/0 Multinodular and vascolating neuronal tumor
9505/1 Ganglioglioma, NOS
9505/3 Ganglioglioma, anaplastic
9508/3 Atypical teratoid/rhabdoid tumor
9509/1 Papillary glioneuronal tumor

NEUROFIBROSARCOMA 954 9540/0 Neurofibroma, NOS

9540/1 Neurofibromatosis, NOS
9540/3 Malignant peripheral nerve sheath tumor
9541/0 Melanotic neurofibroma

PLEXIFORM NEUROFIBROMA 955 9550/0 Plexiform neurofibroma

NEURILEMMOMA 956 9560/0 Neurilemoma, NOS

9560/1 Melanotic schwannoma
9560/3 Neurilemmoma, malignant
9561/3 MPNST with rhabdomyoblastic differentiation
9562/0 Neurothekeoma

PERINEURIOMA 957 9570/0 Neuroma, NOS

9571/0 Perineurioma, NOS
9571/3 Perineurioma, malignant
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 345
BRAIN, & CRANIALNERVES, & SPINAL CORD, (EXCL. VENTRICLE, CEREBELLUM) C710-C714, C717-C719, C720-C725
MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS
9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 346
BRAIN, & CRANIALNERVES, & SPINAL CORD, (EXCL. VENTRICLE, CEREBELLUM) C710-C714, C717-C719, C720-C725
NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

MYELOID SARCOMA 993 9930/3 Myeloid sarcoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 347
VENTRICLE C715
NEOPLASM 800 8000/0 Neoplasm, benign
8000/1 Neoplasm, uncertain whether benign or malignant
8000/3 Neoplasm, malignant
8001/0 Tumor cells, benign
8001/1 Tumor cells, uncertain whether benign or malignant
8001/3 Tumor cells, malignant
8005/3 Malignant tumor, clear cell type

TERATOMA 908 9085/3 Mixed germ cell tumor

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GLIOMA 938 9380/3 Glioma, malignant

9381/3 Gliomatosis cerebri
9382/3 Mixed glioma
9383/1 Subependymoma
9384/1 Supependymal giant cell astrocytoma
9385/3 Diffuse midline glioma, H3 K27M-mutant

EPENDYMOMA, NOS 939 9390/0 Choroid plexus papilloma, NOS

9390/1 Atypical choroid plexus papilloma
9390/3 Choroid plexus papilloma, malignant
9391/3 Ependymoma, NOS
9392/3 Ependymoma, anaplastic
9393/3 Papillary ependymoma
9396/3 Ependymoma, RELA fusion-positive

ASTROCYTOMA, NOS 940 9400/3 Astrocytoma, NOS

9401/3 Astrocytoma, anaplastic

PROTOPLASMIC ASTROCYTOMA 941 9410/3 Protoplasmic astrocytoma

9411/3 Gemistocytic astrocytoma

FIBRILLARY ASTROCYTOMA 942 9420/3 Fibrillary astrocytoma

9421/1 Pilocytic astrocytoma
9421/3 Pilocytic astrocytoma
9423/3 Polar spongioblastoma
9424/3 Pleomorphic xanthoastrocytoma
9425/3 Pilomyxoid astrocytoma

ASTROBLASTOMA 943 9430/3 Astroblastoma

9431/1 Angiocentric glioma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 348
VENTRICLE C715
GLIOBLASTOMA, NOS 944 9440/3 Glioblastoma, NOS
9441/3 Giant cell glioblastoma
9442/3 Gliosarcoma
9444/1 Chordoid glioma
9445/3 Glioblastoma, IDH-mutant

OLIGODENDROGLIOMA, NOS 945 9450/3 Oligodendroglioma, NOS

9451/3 Oligodendroglioma, anaplastic

MEDULLOBLASTOMA, NOS 947 9473/3 Primitive neuroectodermal tumor

9475/3 Medulloblastoma, WNT-activated
9476/3 Medulloblastoma, SHH-activated and TP53-mutant
9477/3 Medulloblastoma, non-WNT/non-SHH
9478/3 Embryonal tumor with multilayered rosettes, NOS

GANGLIONEUROBLASTOMA 949 9490/0 Ganglioneuroma

9490/3 Ganglioneuroblastoma
9492/0 Gangliocytoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9505/1 Ganglioglioma, NOS
9505/3 Ganglioglioma, anaplastic
9506/1 Centrol neurocytoma
9508/3 Atypical teratoid/rhabdoid tumor
9509/1 Papillary glioneuronal tumor

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 349
VENTRICLE C715
FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9749/1 Juvenile xanthogranuloma

9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 350
VENTRICLE C715
PRECURSOR LYMPHOID NEOPLASMS 981 9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 351
CEREBELLUM C716
NEOPLASM 800 8000/0 Neoplasm, benign
8000/1 Neoplasm, uncertain whether benign or malignant
8000/3 Neoplasm, malignant
8001/0 Tumor cells, benign
8001/1 Tumor cells, uncertain whether benign or malignant
8001/3 Tumor cells, malignant
8005/3 Malignant tumor, clear cell type

SARCOMA, NOS 880 8800/0 Soft tissue tumor, benign

8800/3 Sarcoma, NOS
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8815/0 Solitary fibrous tumor

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

LIPOSARCOMA NEOPLASMS 885 8850/0 Lipoma, NOS

TERATOMA 908 9080/0 Teratoma, benign

9080/1 Teratoma, NOS
9080/3 Teratoma, malignant, NOS
9084/0 Dermoid cyst, NOS

BLOOD VESSEL TUMORS 912 9120/0 Hemangioma, NOS

HEMANGIOENDOTHELIOMA 913 9131/0 Capillary hemangioma

HEMANGIOPERICYTOMA 915 9150/1 Hemangiopericytoma, NOS

HEMANGIOBLASTOMA 916 9161/1 Hemangioblastoma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GLIOMA 938 9380/3 Glioma, malignant

9381/3 Gliomatosis cerebri
9382/3 Mixed glioma
9383/1 Subependymoma
9385/3 Diffuse midline glioma, H3 K27M-mutant
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 352
CEREBELLUM C716
EPENDYMOMA, NOS 939 9391/3 Ependymoma, NOS
9392/3 Ependymoma, anaplastic
9393/3 Papillary ependymoma
9396/3 Ependymoma, RELA fusion-positive

ASTROCYTOMA, NOS 940 9400/3 Astrocytoma, NOS

9401/3 Astrocytoma, anaplastic

PROTOPLASMIC ASTROCYTOMA 941 9410/3 Protoplasmic astrocytoma

9411/3 Gemistocytic astrocytoma

FIBRILLARY ASTROCYTOMA 942 9420/3 Fibrillary astrocytoma

9421/1 Pilocytic astrocytoma
9421/3 Pilocytic astrocytoma
9424/3 Pleomorphic xanthoastrocytoma
9425/3 Pilomyxoid astrocytoma

ASTROBLASTOMA 943 9430/3 Astroblastoma

9431/1 Angiocentric glioma

GLIOBLASTOMA, NOS 944 9440/3 Glioblastoma, NOS

9441/3 Giant cell glioblastoma
9442/3 Gliosarcoma
9445/3 Glioblastoma, IDH-mutant

OLIGODENDROGLIOMA, NOS 945 9450/3 Oligodendroglioma, NOS

9451/3 Oligodendroglioma, anaplastic

MEDULLOBLASTOMA, NOS 947 9470/3 Medulloblastoma, NOS

9471/3 Desmoplastic medulloblastoma
9472/3 Medullomyoblastoma
9473/3 Primitive neuroectodermal tumor
9474/3 Large cell medulloblastoma
9475/3 Medulloblastoma, WNT-activated
9476/3 Medulloblastoma, SHH-activated and TP53-mutant
9477/3 Medulloblastoma, non-WNT/non-SHH
9478/3 Embryonal tumor with multilayered rosettes, NOS

CEREBELLAR SARCOMA, NOS 948 9480/3 Cerebellar sarcoma, NOS

GANGLIONEUROBLASTOMA 949 9490/0 Ganglioneuroma

9490/3 Ganglioneuroblastoma
9492/0 Gangliocytoma
9493/0 Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos)
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 353
CEREBELLUM C716
NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS
9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9505/1 Ganglioglioma, NOS
9506/1 Centrol neurocytoma
9508/3 Atypical teratoid/rhabdoid tumor
9509/0 Multinodular and vacuolating neuronal tumor
9509/1 Papillary glioneuronal tumor
9509/3 Diffuse leptomeningeal glioneuronal tumor

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 354
CEREBELLUM C716
PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS
9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 355
OTHER NERVOUS SYSTEM C728-C729
NEOPLASM 800 8000/0 Neoplasm, benign
8000/1 Neoplasm, uncertain whether benign or malignant
8000/3 Neoplasm, malignant
8001/0 Tumor cells, benign
8001/1 Tumor cells, uncertain whether benign or malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

SARCOMA, NOS 880 8800/0 Soft tissue tumor, benign

8800/3 Sarcoma, NOS
8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

LIPOSARCOMA NEOPLASMS 885 8850/0 Lipoma, NOS

8850/1 Atypical lipoma
8850/3 Liposarcoma, NOS

ANGIOLIPOMA 886 8861/0 Angiolipoma, NOS

MYOMATOUS NEOPLASMS 889 8890/0 Leiomyoma, NOS

8890/1 Leiomyomatosis, nOS
8890/3 Leiomyosarcoma, NOS
8897/1 Smooth muscle tumor, NOS

RHABDOMYOSARCOMA, NOS 890 8900/0 Rhabdomyoma, NOS

8900/3 Rhabdomyosarcoma, NOS

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

GERM CELL TUMORS 906 9064/3 Germinoma

TERATOMA 908 9080/1 Teratoma, NOS

9080/3 Teratoma, malignant, NOS
9082/3 Malignant teratoma, undiff.
9084/0 Dermoid cyst, NOS
9084/3 Teratoma with malig. transformation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 356
OTHER NERVOUS SYSTEM C728-C729
BLOOD VESSEL TUMORS 912 9120/0 Hemangioma, NOS
9120/3 Hemangiosarcoma
9121/0 Cavernous hemangioma

HEMANGIOENDOTHELIOMA 913 9130/0 Hemangioendothelioma, benign

9130/1 Hemangioendothelioma, NOS
9130/3 Hemangioendothelioma, malignant

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

HEMANGIOPERICYTOMA 915 9150/0 Hemangiopericytoma, benign

9150/1 Hemangiopericytoma, NOS
9150/3 Hemangiopericytoma, malignant

HEMANGIOBLASTOMA 916 9161/1 Hemangioblastoma

EWING SARCOMA 926 9260/3 Ewing sarcoma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9508/3 Atypical teratoid/rhabdoid tumor

NEUROFIBROSARCOMA 954 9540/0 Neurofibroma, NOS

9540/1 Neurofibromatosis, NOS
9540/3 Malignant peripheral nerve sheath tumor
9541/0 Melanotic neurofibroma

PLEXIFORM NEUROFIBROMA 955 9550/0 Plexiform neurofibroma

NEURILEMMOMA 956 9560/0 Neurilemoma, NOS

9560/3 Neurilemmoma, malignant
9561/3 MPNST with rhabdomyoblastic differentiation
9562/0 Neurothekeoma

PERINEURIOMA 957 9570/0 Neuroma, NOS

9571/0 Perineurioma, NOS
9571/3 Perineurioma, malignant
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 357
OTHER NERVOUS SYSTEM C728-C729
MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS
9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS

T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome

9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 358
OTHER NERVOUS SYSTEM C728-C729
PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
9827/3 Adult T-cell leukemia/lymphoma (HTLV-1 pos.)

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

MYELOID LEUKEMIA, NOS 986 9861/3 Acute myeloid leukemia

MYELOID SARCOMA 993 9930/3 Myeloid sarcoma

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 359
OTHER NERVOUS SYSTEM C728-C729
CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 360
THYROID GLAND C739
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 361
THYROID GLAND C739
ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8251/3 Alveolar adenocarcinoma

8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

FOLLICULAR ADENOCARCINOMA, NOS 833 8330/3 Follicular adenocarcinoma, NOS

8331/3 Follicular adenocarcinoma well diff.
8332/3 Follicular adenocarcinoma trabecular
8333/3 Fetal adenocarcinoma
8335/3 Follicular carcinoma, minimally invasive
8337/3 Insular carcinoma
8339/3 Follicular thyroid carcinoma (FTC), encapsulated angioinvasive

PAPILLARY & FOLLICULAR ADENOCA. 834 8340/3 Papillary carcinoma, follicular variant
8341/3 Papillary microcarcinoma
8342/3 Papillary carcinoma, oxyphilic cell
8343/2 Non-invasive EFVPTC
8343/3 Papillary carcinoma, encapsulated
8344/3 Papillary carcinoma, columnar cell
8345/3 Medullary carcinoma with amyloid stroma
8346/3 Mixed medullary-follicular carcinoma
8347/3 Mixed medullary-papillary carcinoma

NONENCAPSUL. SCLEROSING CA. 835 8350/3 Nonencapsulated sclerosing carcinoma

PAPILLARY CYSTADENOCA., NOS 845 8450/3 Papillary cystadenocarcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 362
THYROID GLAND C739

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 363
THYROID GLAND C739
T-CELL LYMPHOMAS 970 9701/3 Sezary syndrome
9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9734/3 Plasmacytoma, extramedullary
9735/3 Plasmablastic lymphoma
9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

MAST CELL TUMORS 974 9740/3 Mast cell sarcoma

9741/3 Malignant mastocytosis
9749/3 Erdhiem-Chester Disease

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9750/3 Malignant histiocytosis
9751/3 Langerhans cell histiocytosis, NOS
9754/3 Langerhans cell histiocytosis, disseminated
9755/3 Histiocytic sarcoma
9756/3 Langerhans cell sarcoma
9757/3 Interdigitating dendritic cell sarcoma
9758/3 Follicular dendritic cell sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9766/3 Lymphomatoid granulomatosis, grade 3

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)
9819/3 B-lymphocytic leukemia/lymphoma, BCR-ABL1-like

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 364
THYROID GLAND C739
PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia
9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 365
ADRENALGLANDS C740-C741,C749
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

ADRENAL CORTICAL CARCINOMA 837 8370/3 Adrenal cortical carcinoma

PARAGANGLIOMA 868 8680/3 Paraganglioma, malignant

EXTRA-ADRENAL PARAGANG., MAL 869 8693/3 Extra-adrenal paraganglioma, malignant

PHEOCHROMOCYTOMA 870 8700/3 Pheochromocytoma

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 366
ADRENALGLANDS C740-C741,C749
EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS
9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 367
PARATHYROIDGLAND C750
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8322/3 Water-clear cell adenocarcinoma
8323/3 Mixed cell adenocarcinoma

PARAGANGLIOMA 868 8680/3 Paraganglioma, malignant

EXTRA-ADRENAL PARAGANG., MAL 869 8693/3 Extra-adrenal paraganglioma, malignant

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 368
PARATHYROIDGLAND C750
EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS
9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 369
PITUITARYGLAND C751
NEOPLASM 800 8000/0 Neoplasm, benign
8000/1 Neoplasm, uncertain whether benign or malignant
8000/3 Neoplasm, malignant
8001/0 Tumor cells, benign
8001/1 Tumor cells, uncertain whether benign or malignant
8001/3 Tumor cells, malignant
8005/0 Clear cell tumor, NOS
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/0 Epithelial tumor, benign

8010/2 Carcinoma in situ, NOS
8010/3 Carcinoma, NOS

ADENOCARCINOMA, NOS 814 8140/0 Adenoma, NOS

8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8146/0 Monomorphic adenoma

PAPILLARY ADENOCARCINOMA, NOS 826 8260/0 Papillary adenoma, NOS

CHROMOPHOBE CARCINOMA 827 8270/0 Chromophobe adenoma

8270/3 Chromophobe carcinoma
8271/0 Prolactinoma
8272/0 Pituitary adenoma, NOS
8272/3 Pituitary carcinoma, NOS
8273/3 Pituitary blastoma

ACIDOPHIL CARCINOMA 828 8280/0 Acidophil adenoma

8280/3 Acidophil carcinoma
8281/0 Mixed acidophil-basophil adenoma
8281/3 Mixed acidophil-basophil carcinoma

OXYPHILIC ADENOCARCINOMA 829 8290/0 Oxyphilic adenoma

8290/3 Oxyphilic adenocarcinoma

BASOPHIL CARCINOMA 830 8300/0 Basophil adenoma

8300/3 Basophil carcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/0 Clear cell adenoma

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/0 Mixed cell adenoma
8323/3 Mixed cell adenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 370
PITUITARYGLAND C751
SARCOMA, NOS 880 8800/0 Soft tissue tumor, benign
8800/3 Sarcoma, NOS

LIPOSARCOMA NEOPLASMS 885 8850/0 Lipoma, NOS

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/0 Teratoma, benign

9080/1 Teratoma, NOS
9080/3 Teratoma, malignant, NOS
9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

CRANIOPHARYNGIOMA 935 9350/1 Craniopharyngioma

9351/1 Adamantinomatous craniopharyngioma
9352/1 Papillary craniopharyngioma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

ASTROBLASTOMA 943 9432/1 Pituicytoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9505/3 Ganglioglioma, anaplastic

GRANULAR CELL TUMOR 958 9580/0 Granular cell tumor, NOS

9582/0 Granular cell tumor of the sellar region

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 371
CRANIOPHARYNGEALDUCT C752
NEOPLASM 800 8000/0 Neoplasm, benign
8000/1 Neoplasm, uncertain whether benign or malignant
8000/3 Neoplasm, malignant
8001/0 Tumor cells, benign
8001/1 Tumor cells, uncertain whether benign or malignant
8001/3 Tumor cells, malignant
8005/0 Clear cell tumor, NOS
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/0 Epithelial tumor, benign

8010/2 Carcinoma in situ, NOS
8010/3 Carcinoma, NOS

ADENOCARCINOMA, NOS 814 8140/0 Adenoma, NOS

8140/2 Adenocarcinoma in situ
8140/3 Adenocarcinoma, NOS
8146/0 Monomorphic adenoma

PAPILLARY ADENOCARCINOMA, NOS 826 8260/0 Papillary adenoma, NOS

CHROMOPHOBE CARCINOMA 827 8270/0 Chromophobe adenoma

8270/3 Chromophobe carcinoma
8271/0 Prolactinoma
8272/0 Pituitary adenoma, NOS
8272/3 Pituitary carcinoma, NOS

ACIDOPHIL CARCINOMA 828 8280/0 Acidophil adenoma

8280/3 Acidophil carcinoma
8281/0 Mixed acidophil-basophil adenoma
8281/3 Mixed acidophil-basophil carcinoma

OXYPHILIC ADENOCARCINOMA 829 8290/0 Oxyphilic adenoma

8290/3 Oxyphilic adenocarcinoma

BASOPHIL CARCINOMA 830 8300/0 Basophil adenoma

8300/3 Basophil carcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/0 Clear cell adenoma

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/0 Mixed cell adenoma
8323/3 Mixed cell adenocarcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 372
CRANIOPHARYNGEALDUCT C752
SARCOMA, NOS 880 8800/0 Soft tissue tumor, benign
8800/3 Sarcoma, NOS

LIPOSARCOMA NEOPLASMS 885 8850/0 Lipoma, NOS

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/0 Teratoma, benign

9080/1 Teratoma, NOS
9080/3 Teratoma, malignant, NOS
9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

CRANIOPHARYNGIOMA 935 9350/1 Craniopharyngioma

9351/1 Adamantinomatous craniopharyngioma
9352/1 Papillary craniopharyngioma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9505/3 Ganglioglioma, anaplastic

GRANULAR CELL TUMOR 958 9580/0 Granular cell tumor, NOS

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 373
PINEAL GLAND C753
NEOPLASM 800 8000/0 Neoplasm, benign
8000/1 Neoplasm, uncertain whether benign or malignant
8000/3 Neoplasm, malignant
8001/0 Tumor cells, benign
8001/1 Tumor cells, uncertain whether benign or malignant
8001/3 Tumor cells, malignant

CARCINOMA, NOS 801 8010/0 Epithelial tumor, benign

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/0 Teratoma, benign

9080/3 Teratoma, malignant, NOS
9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/0 Dermoid cyst, NOS
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

PERIPHERAL NEUROECTODERMAL TUMOR 936 9360/1 Pinealoma, NOS

9361/1 Pineocytoma
9362/3 Pineoblastoma

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

EPENDYMOMA, NOS 939 9395/3 Papillary tumor of pineal region

MEDULLOBLASTOMA, NOS 947 9473/3 Primitive neuroectodermal tumor

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

9492/0 Gangliocytoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9505/1 Ganglioglioma, NOS
9505/3 Ganglioglioma, anaplastic
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 374
PINEAL GLAND C753

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 375
OTHER ENDOCRINE GLANDS C754-C755,C758-C759
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

PARAGANGLIOMA 868 8680/3 Paraganglioma, malignant

8681/3 Sympathetic paraganglioma
8682/3 Parasympathetic paraganglioma

EXTRA-ADRENAL PARAGANG., MAL 869 8690/3 Middle ear paraganglioma

8691/3 Aortic body tumor, malignant
8692/3 Carotid body tumor, malignant
8693/3 Extra-adrenal paraganglioma, malignant
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 376
OTHER ENDOCRINE GLANDS C754-C755,C758-C759
GERM CELL TUMORS 906 9060/3 Dysgerminoma
9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma

TERATOMA 908 9080/3 Teratoma, malignant, NOS

9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 377
ILL-DEFINED C760-C768
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/3 Carcinoma, NOS

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

NON-SMALL CELL CARCINOMA, NOS 804 8046/3 Non-small cell carcinoma

PAPILLARY CARCINOMA, NOS 805 8051/3 Verrucous carcinoma, NOS

8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell

LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma

8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8121/3 Schneiderian carcinoma

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8255/3 Adenocarcinoma with mixed subtypes

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

PAPILLARY CYSTADENOCA., NOS 845 8450/3 Papillary cystadenocarcinoma, NOS

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 378
ILL-DEFINED C760-C768
MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma
8481/3 Mucin-producing adenocarcinoma

LOBULAR AND OTHER DUCTAL CA. 852 8525/3 Polymorphous low grade adenocarcinoma

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

ADENOSQUAMOUS CARCINOMA 856 8562/3 Epithelial-myoepithelial carcinoma

MIXED TUMOR, MALIGNANT, NOS 894 8941/3 Carcinoma in pleomorphic adenoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

FOLLIC. & MARGINAL LYMPH, NOS 969 9699/3 Marginal zone B-cell lymphoma, NOS

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 379
LYMPH NODES C770-C775,C778-C779
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
9678/3 Primary effusion lymphoma
9679/3 Mediastinal large B-cell lymphoma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9688/3 T-cell histiocyte rich large B-cell lymphoma
9689/3 Splenic marginal zone B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 380
LYMPH NODES C770-C775,C778-C779
T-CELL LYMPHOMAS 970 9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
9708/3 Subcutaneous panniculitis-like T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9712/3 Intravascular large B-cell lymphoma
9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9715/3 Anaplastic large cell lymphoma, ALK negative
9716/3 Hepatosplenic gamma-delta cell lymphoma
9717/3 Intestinal T-cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9724/3 SystemicEBV pos. T-cell lymphoproliferative disease of childhood
9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9735/3 Plasmablastic lymphoma

9737/3 ALK positive large B-cell lymphoma
9738/3 Lrg B-cell lymphoma in HHV8-assoc. multicentric Castleman DZ

NEOPLASMS OF HISTIOCYTES AND ACCESSORY LYMPHOID CELLS 975 9751/3 Langerhans cell histiocytosis, NOS
9755/3 Histiocytic sarcoma
9759/3 Fibroblastic reticular cell tumor

IMMUNOPROLIFERATIVE DISEASES 976 9761/3 Waldenstrom macroglobulinemia

9762/3 Heavy chain disease, NOS

PRECURSOR LYMPHOID NEOPLASMS 981 9811/3 B lymphoblastic leukemia/lymphoma, NOS

9812/3 Leukemia/lymphoma with t(9;22)(q34;q11.2);BCR-ABL1
9813/3 Leukemia/lymphoma with t(v;11q23);MLL rearranged
9814/3 Leukemia/lymphoma with t(12;21)(p13;q22);TEL-AML1(ETV6-RUNX1)
9815/3 B lymphoblastic leukemia/lymphoma with hyperdiploidy
9816/3 Leukemia/lymphoma with hypodiploidy (hypodiploid ALL)
9817/3 B lymphblastic leukemia/lymphoma with t(5;14)(q31;q32);IL3-IGH
9818/3 Leukemia/lymphoma with t(1;19)(q23;p13.3); E2A PBX1 (TCF3 PBX1)

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma

PROLYMPH/PRECURS LEUKEMIA 983 9831/3 T-cell large granular lymphocytic leukemia

9837/3 T lymphoblastic leukemia/lymphoma

CHRONIC MYELOPROLIFERATIVE DIS. 996 9965/3 Myeloid and lymphoid neoplasms with PDGFRB rearrangement
9967/3 Myeloid and lymphoid neoplasm with FGFR1 abnormalities

MYELOPLASTIC/MYELOPROLIFERATIVE NEOPLASMS 997 9971/3 Polymorphic PTLD

9975/3 Myelodysplastic/Myeloproliferative neoplasm, unclassifiable
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 381
UNKNOWN C809
NEOPLASM 800 8000/3 Neoplasm, malignant
8001/3 Tumor cells, malignant
8002/3 Malignant tumor, small cell type
8003/3 Malignant tumor, giant cell type
8004/3 Malignant tumor, spindle cell type
8005/3 Malignant tumor, clear cell type

CARCINOMA, NOS 801 8010/2 Carcinoma in situ, NOS

8010/3 Carcinoma, NOS
8011/3 Epithelioma, malignant
8012/3 Large cell carcinoma, NOS
8013/3 Large cell neuroendocrine carcinoma
8014/3 Large cell carcinoma with rhabdoid phenotype
8015/3 Glassy cell carcinoma

CARCINOMA, UNDIFF., NOS 802 8020/3 Carcinoma, undifferentiated type, NOS

8021/3 Carcinoma, anaplastic type, NOS
8022/3 Pleomorphic carcinoma

GIANT & SPINDLE CELL CARCINOMA 803 8030/3 Giant cell and spindle cell carcinoma
8031/3 Giant cell carcinoma
8032/3 Spindle cell carcinoma
8033/3 Pseudosarcomatous carcinoma
8034/3 Polygonal cell carcinoma
8035/3 Carcinoma with osteoclast-like giant cells

SMALL CELL CARCINOMA, NOS 804 8041/3 Small cell carcinoma, NOS
8043/3 Small cell carcinoma, fusiform cell

PAPILLARY CARCINOMA, NOS 805 8050/2 Papillary carcinoma in situ

8050/3 Papillary carcinoma, NOS
8051/3 Verrucous carcinoma, NOS
8052/2 Papillary squamous cell carcinoma, non-invasive
8052/3 Papillary squamous cell carcinoma

SQUAMOUS CELL CARCINOMA, NOS 807 8070/2 Squamous cell carcinoma in situ, NOS
8070/3 Squamous cell carcinoma, NOS
8071/3 Sq. cell carcinoma, keratinizing, NOS
8072/3 Sq. cell carcinoma, lg. cell, non-ker.
8073/3 Sq. cell carcinoma, sm. cell, non-ker.
8074/3 Sq. cell carcinoma, spindle cell
8075/3 Squamous cell carcinoma, adenoid
8076/2 Sq. cell carc. in situ with question. stromal invas.
8076/3 Sq. cell carcinoma, micro-invasive
8078/3 Squamous cell carcinoma with horn formation
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 382
UNKNOWN C809
LYMPHOEPITHELIAL CARCINOMA 808 8082/3 Lymphoepithelial carcinoma
8083/3 Basaloid squamous cell carcinoma
8084/3 Squamous cell carcinoma, clear cell type

TRANSITIONAL CELL CARCINOMA, NOS 812 8120/2 Transitional cell carcinoma in situ
8120/3 Transitional cell carcinoma, NOS
8121/3 Schneiderian carcinoma
8122/3 Trans. cell carcinoma, spindle cell
8123/3 Basaloid carcinoma
8124/3 Cloacogenic carcinoma

PAPILLARY TRANS. CELL CARCINOMA 813 8130/2 Papillary trans. cell carcinoma, non-invasive
8130/3 Papillary trans. cell carcinoma
8131/3 Transitional cell carcinoma, micropapillary

ADENOCARCINOMA, NOS 814 8140/2 Adenocarcinoma in situ

8140/3 Adenocarcinoma, NOS
8141/3 Scirrhous adenocarcinoma
8143/3 Superficial spreading adenocarcinoma
8147/3 Basal cell adenocarcinoma

ENDOCRINOMAS 815 8152/3 Glucagonoma, malignant

8153/3 Gastrinoma, malignant
8156/3 Somatostatinoma, malignant
8157/3 Enteroglucagonoma, malignant

TRABECULAR ADENOCARCINOMA 819 8190/3 Trabecular adenocarcinoma

ADENOID CYSTIC & CRIBRIFORM CA. 820 8200/3 Adenoid cystic carcinoma
8201/2 Cribriform carcinoma in situ
8201/3 Cribriform carcinoma

ADENOCA. IN ADENOMA. POLYP 821 8210/2 Adenocarcinoma in situ in adenomatous polyp

8210/3 Adenocarcinoma in adenomatous polyp
8211/3 Tubular adenocarcinoma

SOLID CARCINOMA, NOS 823 8230/2 Duct carcinoma in situ, solid type
8230/3 Solid carcinoma, NOS
8231/3 Carcinoma simplex

CARCINOID TUMOR, MALIGNANT 824 8240/3 Carcinoid tumor, malignant

8241/3 Enterochromaffin cell carcinoid
8242/3 Enterochromaffin-like cell tumor, malignant
8243/3 Goblet cell carcinoid
8244/3 Composite carcinoid
8245/3 Adenocarcinoid tumor
8246/3 Neuroendocrine carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 383
UNKNOWN C809
CARCINOID TUMOR, MALIGNANT 824 8249/3 Neuroendocrine tumor

BRONCHIOLO-ALVEOLAR ADENOCA. 825 8251/3 Alveolar adenocarcinoma

8255/3 Adenocarcinoma with mixed subtypes

PAPILLARY ADENOCARCINOMA, NOS 826 8260/3 Papillary adenocarcinoma, NOS

8261/2 Adenocarcinoma in situ in villous adenoma
8261/3 Adenocarcinoma in villous adenoma
8262/3 Villous adenocarcinoma
8263/2 Adenocarcinoma in situ in tubulovillous adenoma
8263/3 Adenocarcinoma in tubulovillous adenoma

OXYPHILIC ADENOCARCINOMA 829 8290/3 Oxyphilic adenocarcinoma

CLEAR CELL ADENOCARCINOMA, NOS 831 8310/3 Clear cell adenocarcinoma, NOS

GRANULAR CELL CARCINOMA 832 8320/3 Granular cell carcinoma

8323/3 Mixed cell adenocarcinoma

ENDOMETRIOID ADENOCARCINOMA 838 8380/3 Endometrioid carcinoma

SWEAT GLAND ADENOCARCINOMA 840 8401/3 Apocrine adenocarcinoma

MUCOEPIDERMOID CARCINOMA 843 8430/3 Mucoepidermoid carcinoma

CYSTADENOCARCINOMA, NOS 844 8440/3 Cystadenocarcinoma, NOS

MUCINOUS ADENOCARCINOMA 848 8480/3 Mucinous adenocarcinoma

8481/3 Mucin-producing adenocarcinoma

SIGNET RING CELL CARCINOMA 849 8490/3 Signet ring cell carcinoma

MEDULLARY CARCINOMA, NOS 851 8510/3 Medullary carcinoma, NOS

LOBULAR AND OTHER DUCTAL CA. 852 8521/3 Infiltrating ductular carcinoma

PAGET DISEASE, EXTRAMAMMARY 854 8542/3 Paget disease, extramammary

ACINAR CELL CARCINOMA 855 8550/3 Acinar cell carcinoma

8551/3 Acinar cell cystadenocarcinoma

ADENOSQUAMOUS CARCINOMA 856 8560/3 Adenosquamous carcinoma

8562/3 Epithelial-myoepithelial carcinoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 384
UNKNOWN C809
ADENOCA. WITH METAPLASIA 857 8570/3 Adenocarcinoma with squamous metaplasia
8571/3 Adenocarcinoma w cartilag. & oss. metaplas.
8572/3 Adenocarcinoma with spindle cell mataplasia
8573/3 Adenocarcinoma with apocrine metaplasia
8574/3 Adenocarcinoma with neuroendocrine differen.
8575/3 Metaplastic carcinoma, NOS

GONADAL NEOPLASMS 863 8630/3 Androblastoma, malignant

LEYDIG CELL TUMOR, MALIGNANT 865 8650/3 Leydig cell tumor, malignant

PARAGANGLIOMA 868 8680/3 Paraganglioma, malignant

EXTRA-ADRENAL PARAGANG., MAL 869 8693/3 Extra-adrenal paraganglioma, malignant

GLOMANGIOSARCOMA 871 8710/3 Glomangiosarcoma

SARCOMA, NOS 880 8800/3 Sarcoma, NOS

8801/3 Spindle cell sarcoma
8802/3 Giant cell sarcoma
8803/3 Small cell sarcoma
8804/3 Epithelioid sarcoma
8805/3 Undifferentiated sarcoma
8806/3 Desmoplastic small round cell tumor

FIBROMATOUS NEOPLASMS 881 8810/3 Fibrosarcoma, NOS

8811/3 Fibromyxosarcoma
8813/3 Fascial fibrosarcoma
8814/3 Infantile fibrosarcoma
8815/3 Solitary fibrous tumor, malignant

SARCOMA, NOS 882 8825/3 Myofibroblastic sarcoma

FIBROUS HISTIOCYTOMA, MAL. 883 8830/3 Fibrous histiocytoma, malignant

MYXOSARCOMA 884 8840/3 Myxosarcoma

LIPOSARCOMA NEOPLASMS 885 8850/3 Liposarcoma, NOS

8851/3 Liposarcoma, well differentiated
8852/3 Myxoid liposarcoma
8853/3 Round cell liposarcoma
8854/3 Pleomorphic liposarcoma
8855/3 Mixed type liposarcoma
8857/3 Fibroblastic liposarcoma
8858/3 Dedifferentiated liposarcoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 385
UNKNOWN C809
MYOMATOUS NEOPLASMS 889 8890/3 Leiomyosarcoma, NOS
8891/3 Epithelioid leiomyosarcoma
8894/3 Angiomyosarcoma
8895/3 Myosarcoma
8896/3 Myxoid leiomyosarcoma

RHABDOMYOSARCOMA, NOS 890 8900/3 Rhabdomyosarcoma, NOS

8901/3 Pleomorphic rhabdomyosarcoma, adult type
8902/3 Mixed type rhabdomyosarcoma

EMBRYONAL RHABDOMYOSARCOMA 891 8910/3 Embryonal rhabdomyosarcoma

8912/3 Spindle cell rhabdomyosarcoma

ALVEOLAR RHABDOMYOSARCOMA 892 8920/3 Alveolar rhabdomyosarcoma

8921/3 Rhabdomyosarcoma with ganglionic differentiation

STROMAL SARCOMA 893 8934/3 Carcinofibroma

8935/3 Stromal sarcoma, NOS

MIXED TUMOR, MALIGNANT, NOS 894 8940/3 Mixed tumor, malignant, NOS
8941/3 Carcinoma in pleomorphic adenoma

MULLERIAN MIXED TUMOR 895 8950/3 Mullerian mixed tumor

8951/3 Mesodermal mixed tumor

CARCINOSARCOMA, NOS 898 8980/3 Carcinosarcoma, NOS

8981/3 Carcinosarcoma, embryonal type
8982/3 Malignant myoepithelioma

MESENCHYMOMA, MALIGNANT 899 8990/3 Mesenchymoma, malignant

8991/3 Embryonal sarcoma

SYNOVIAL SARCOMA, NOS 904 9040/3 Synovial sarcoma, NOS

9041/3 Synovial sarcoma, spindle cell
9042/3 Synovial sarcoma, epithelioid cell
9043/3 Synovial sarcoma, biphasic
9044/3 Clear cell sarcoma,NOS (except of kidney M-8964/3)

GERM CELL TUMORS 906 9060/3 Dysgerminoma

9064/3 Germinoma
9065/3 Germ cell tumor, nonseminomatous

EMBRYONAL CARCINOMA, NOS 907 9070/3 Embryonal carcinoma, NOS

9071/3 Yolk sac tumor
9072/3 Polyembryoma
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 386
UNKNOWN C809
TERATOMA 908 9080/3 Teratoma, malignant, NOS
9081/3 Teratocarcinoma
9082/3 Malignant teratoma, undiff.
9083/3 Malignant teratoma, intermediate
9084/3 Teratoma with malig. transformation
9085/3 Mixed germ cell tumor

CHORIOCARCINOMA 910 9100/3 Choriocarcinoma

9101/3 Choriocarcinoma combined w/ other germ cell elements
9102/3 Malignant teratoma, trophoblastic
9105/3 Trophoblastic tumor, epithelioid

MESONEPHROMA, MALIGNANT 911 9110/3 Mesonephroma, malignant

BLOOD VESSEL TUMORS 912 9120/3 Hemangiosarcoma

HEMANGIOENDOTHELIOMA 913 9130/3 Hemangioendothelioma, malignant

9133/3 Epithelioid hemangioendothelioma, malignant

KAPOSI SARCOMA 914 9140/3 Kaposi sarcoma

HEMANGIOPERICYTOMA 915 9150/3 Hemangiopericytoma, malignant

LYMPHANGIOSARCOMA 917 9170/3 Lymphangiosarcoma

AMELOBLASTOMA, MALIGNANT 931 9310/3 Ameloblastoma, malignant

CHORDOMA 937 9370/3 Chordoma, NOS

9371/3 Chondroid chordoma
9372/3 Dedifferentiated chordoma

GANGLIONEUROBLASTOMA 949 9490/3 Ganglioneuroblastoma

NEUROBLASTOMA, NOS 950 9500/3 Neuroblastoma, NOS

9501/3 Medulloepithelioma, NOS
9502/3 Teratoid medulloepithelioma
9503/3 Neuroepithelioma, NOS
9504/3 Spongioneuroblastoma
9505/3 Ganglioglioma, anaplastic

OLFACTORY NEUROGENIC TUMOR 952 9520/3 Olfactory neurogenic tumor

NEUROFIBROSARCOMA 954 9540/3 Malignant peripheral nerve sheath tumor

ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 387
UNKNOWN C809
NEURILEMMOMA 956 9560/3 Neurilemmoma, malignant
9561/3 MPNST with rhabdomyoblastic differentiation

PERINEURIOMA 957 9571/3 Perineurioma, malignant

GRANULAR CELL TUMOR 958 9580/3 Granular cell tumor, malignant

9581/3 Alveolar soft part sarcoma

MALIGNANT LYMPHOMA, NOS 959 9590/3 Malignant lymphoma, NOS

9591/3 Malignant lymphoma, non-Hodgkin
9596/3 Composite Hodgkin and non-Hodgkin lymphoma

HODGKIN LYMPHOMA 965 9650/3 Hodgkin lymphoma, NOS

9651/3 Hodgkin lymphoma, lymphocyte-rich
9652/3 Hodgkin lymphoma, mixed cellularity, NOS
9653/3 Hodgkin lymphoma, lymphocytic deplet., NOS
9654/3 Hodgkin lymph., lymphocyt. deplet., diffuse fibrosis
9655/3 Hodgkin lymphoma, lymphocyt. deplet., reticular
9659/3 Hodgkin lymph., nodular lymphocyte predom.

HODGKIN LYMPHOMA, NOD. SCLER. 966 9661/3 Hodgkin granuloma [obs]

9662/3 Hodgkin sarcoma [obs]
9663/3 Hodgkin lymphoma, nodular sclerosis, NOS
9664/3 Hodgkin lymphoma, nod. scler., cellular phase
9665/3 Hodgkin lymphoma, nod. scler., grade 1
9667/3 Hodgkin lymphoma, nod. scler., grade 2

ML, SMALL B-CELL LYMPHOCYTIC 967 9670/3 ML, small B lymphocytic, NOS
9671/3 ML, lymphoplasmacytic
9673/3 Mantle cell lymphoma
9675/3 ML, mixed sm. and lg. cell, diffuse
9678/3 Primary effusion lymphoma
9679/3 Mediastinal large B-cell lymphoma

ML, LARGE B-CELL, DIFFUSE 968 9680/3 ML, large B-cell, diffuse
9684/3 ML, large B-cell, diffuse, immunoblastic, NOS
9687/3 Burkitt lymphoma, NOS
9689/3 Splenic marginal zone B-cell lymphoma

FOLLIC. & MARGINAL LYMPH, NOS 969 9690/3 Follicular lymphoma, NOS
9691/3 Follicular lymphoma, grade 2
9695/3 Follicular lymphoma, grade 1
9698/3 Follicular lymphoma, grade 3
9699/3 Marginal zone B-cell lymphoma, NOS
ICD-0-3 SEER SITE/HISTOLOGY VALIDATION LIST April 29, 2022 388
UNKNOWN C809
T-CELL LYMPHOMAS 970 9702/3 Mature T-cell lymphoma, NOS
9705/3 Angioimmunoblastic T-cell lymphoma
9708/3 Subcutaneous panniculitis-like T-cell lymphoma

OTHER SPEC. NON-HODGKIN LYMPHOMA 971 9714/3 Anaplastic large cell lymphoma, T-cell and Null cell type
9716/3 Hepatosplenic gamma-delta cell lymphoma
9717/3 Intestinal T-cell lymphoma
9719/3 NK/T-cell lymphoma, nasal and nasal-type

PRECURS. CELL LYMPHOBLASTIC LYMPH. 972 9727/3 Precursor cell lymphoblastic lymphoma, NOS
9728/3 Precursor B-cell lymphoblastic lymphoma
9729/3 Precursor T-cell lymphoblastic lymphoma

PLASMA CELL TUMORS 973 9731/3 Plasmacytoma, NOS

9732/3 Multiple myeloma
9734/3 Plasmacytoma, extramedullary

LYMPHOID LEUKEMIA, NOS 982 9823/3 Chronic lymphocytic leukemia/small lymphocytic lymphoma